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ABSTRACT
An Examination of the Differences in Risk Factors and their Association with Variations in HIV
Prevalence between Cameroon, Cote d’Ivoire, and Senegal
(Under the direction of RICHARD ROTHENBERG, M.D., M.P.H. FACULTY
MEMBER)
Background: Extensive evidence suggests there are large variations in the prevalence of HIV
infection among Sub-Saharan African countries. Some studies associated these variations in HIV
prevalence to differences in the rate of HIV spread while others attributed the variations to risky
sexual behaviors. The purpose of this study was to examine differences in risk factors for HIV
infection between Cameroon, Cote d’Ivoire, and Senegal, to determine the association between
HIV status and risk factors within and among countries, and identify best predictive risk factors
that help explain variations in HIV prevalence.
Methods: A cross-sectional study was conducted using nationally representative data from The
Demographic and Health Surveys Program. Population-based samples of adults aged 15-49
representing 21,878 in Cameroon (2011), 14,682 in Cote d’Ivoire (2011-2012), and 20,102 in
Senegal (2010-2011) were used in the study. Descriptive analysis and binary logistic regression
were performed using IBM Statistical Package for the Social Sciences. Odds ratios and 95%
confidence interval were calculated, and models were explored.
Results: There are statistically significant (p<.001) differences in HIV risk factors between
Cameroon, Cote d’Ivoire and Senegal. More men and women were engaged in risky behaviors
including having two and more sexual partners in the last 12 months in Cameroon (9.5%) and
Cote d’Ivoire (9.3%) than men and women in Senegal (1.4%). The results of the multivariate
analysis of the association between HIV status and country indicators and risk factors showed
Cameroon at significantly greater increased odds (OR= 2.97; 2.18-4.03; p<.001) of HIV
infection than Cote d’Ivoire (OR=2.57; 1.89-3.50; p<.001) in reference to Senegal. The fact that
the country indicators are strong and significant indicates that not all the variation in HIV
prevalence is explained by the risk factors but only some of it is. Additionally, the forward LR
analysis suggests that Cote d’Ivoire has more risk factors (7) associated with HIV infection than
Cameroon (5) or Senegal does (4).
Conclusion: There are differences in risk factors among the three countries and these differences
can explain some of the variations in HIV prevalence. Further research is necessary to help
capture variations in HIV prevalence that cannot be explained by differences in risk factors.
These findings will help advance prevention efforts.

KEYWORDS: HIV, AIDS, risk factors, HIV infection, HIV prevalence, Sub-Saharan Africa
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CHAPTER I
INTRODUCTION
1.1Background
Human Immunodeficiency virus (HIV) has been in existence for centuries evolving from
animal form (Simian immunodeficiency virus) to human version (CDC, 2014). The human
version of the virus is in two forms: HIV-1 and HIV-2. These two types are responsible for
the majority of HIV infection around the world. Paradoxically, HIV-1 and HIV-2 are mostly
found in the Western African region (Gilbert et al. 2003; Leonard et al., 2000; Nsagha, 2012;
Willems, 2009).
In the human body, the virus attacks cells of the immune system particularly T-cells or
CD4 cells. When left untreated, HIV viruses can completely destroy CD4 cells to their lowest
point (< 200 counts/mm3) leaving then the body vulnerable to all kinds of infections and
diseases. In the body, HIV follows three stages of development. The first stage also called
acute retroviral syndrome occurs within 4 weeks of the moment the person was infected.
During this initial phase, AIDS virus replicated at a rapid rate leading the viral load to reach
its peak. At the acute stage, an infected person can easily transmit the virus and at a heavy
load. During the second phase or also called stage of dormancy, or asymptomatic, or chronic
HIV infection, the virus slows its course of replication. Accordingly, an individual who is
affected by HIV can enjoy normal life and live longer with the assistance of drugs to stabilize
his/her CD4 levels. In the last stage, also called acquired immunodeficiency syndrome
(AIDS), the virus resumes its replication activity destroying along CD4 cells. This process
weakens the immune system and makes the body susceptible to all opportunistic diseases. As

9

a result, an individual with AIDS who is ill with other diseases can die within year if no
intensive treatment is provided (AIDS.Gov, 2013a; CDC, 2014).
The paths through which HIV transmission occurs also are critical for the development of
effective prevention programs. According to AIDS.Gov (2013a) and CDC (2014), HIV
transmission can occur through unprotected sexual contact (anal sex, vaginal sex, sexual
transmitted infections, and multiple sexual partners), sharing of infected injection drug
needles or syringes, mother-to-child transmission (during pregnancy, delivery, and
breastfeeding), occupational exposure, and blood transfusion and organ transplant. Therefore,
it is crucial that HIV infection be monitored to reduce its destructive effects and help save
lives.
Since its debut, HIV has continued to spread and affect the lives of millions of people
every year throughout the world. According to the 2013 report of the Joint United Nations
Programme on HIV/AIDS (UNAIDS, 2013), an estimated 35.3 (32.2-38.8) millions of
people worldwide were living with AIDS virus in 2012. Globally, 2.3 (1.9-2.7) millions
people were newly HIV infected and an estimated 1.6 (1.4-1.9) millions lost their lives to
AIDS in 2012.Unlike other parts of the world, Sub-Saharan Africa has remained the most
affected by this epidemic with an estimated 25 (23.5-26.6) millions adults and children living
with HIV in 2012. HIV incidence in the region was estimated to 1.6 (1.4-1.8) millions and
deaths due to AIDS approximated 1.2 (1.1-1.3) millions in 2012 (UNAIDS, 2013). This
vulnerability was blamed in part on the failure of many Sub-Saharan African countries to
acknowledge HIV disease in its early debut, and promptly develop preventive and
intervention measures, and health policies to protect lives (Weir et al., 2003; Ainsworth &
Teokul, 2000). However, one country in the region, Senegal made the difference by standing
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up early in the battle against HIV/AIDS particularly at the onset of its first six cases in 1986
(Foley and Nguer, 2010; Gilbert, 2008; Putzel, 2006; Willems, 2009).
1.1.1. Senegal
The immediate interest of Senegal in understanding the basics of AIDS virus and
designing preventive measures and programs from the start has earned the support of
political parties, religious and community leaders, and non-governmental organizations
(Foley and Nguer,2010; Putzel, 2006; Willems, 2009). Accordingly, the National Committee
for the Fight against HIV was established the same year to prevent HIV/AIDS from
spreading throughout the country (Foley & Nguer, 2010, Willems, 2009). The adopted
prevention strategies included blood transfusion screening, promotion of safer sexual
behaviors and use of condoms, screening and treatment of sexually transmitted infections
(STIs), sentinel surveillance system, and intervention programs for people at high risk
(Desclaux, 2004; Foley & Nguer, 2010; Willems, 2009). Beyond these preventive measures,
Senegal has also benefited from a certain number of factors including the presence in
majority of the non virulent HIV strains in its society, political stability, cultural strongholds,
efficient use of international funded resources, and leadership in international HIV research
(Gilbert et al., 2003; Willems, 2009).
Since then, Senegal has consistently maintained low rate of HIV prevalence in the
general population (Ansari & Gaestel, 2010; ANSD, 2012; UNAIDS, 2012, 2013).
According to UNAIDS (2012), the estimated HIV prevalence in the adult population aged
15-49 was 0.5% (0.4%-0.6%). The report also indicated that the estimated new cases of HIV
infections among Senegalese all ages have dropped from 4700 (3900-5700) in 2001 to reach
2000 (1300-3000) in 2012 (UNAIDS, 2013). Further, the record showed that the number of

11

deaths due to AIDS still accounted for the lowest in the Sub-Saharan region. Thus, the
consistency in low HIV prevalence of Senegal has drawn the attention of the world which
has set the country as a role model for the rest of the Sub-Saharan African countries.
1.1.2. Cameroon
Unlike Senegal, Cameroon has entered the HIV battle field late and in slow pace. In 1986,
when Senegalese discovered its first six cases of HIV infection, Cameroon had been already
facing 21 cases (Buvé et al., 2001). Despite the early presence of HIV infection in the
country, no efforts were made to address the issue. Fifteen years later, the number of new
HIV infections has skyrocketed to reach 560,000 (390,000-810,000); and the rate of HIV
infection among adults and children was estimated to 6.9 (4.8-9.8) at the end of 2003
(UNAIDS, 2004a). Since then, many efforts have been made to stabilize and reduce the
prevalence of HIV infection in the country. Preventive measures included coverage of
antiretroviral therapy, monitoring of HIV Drug Resistance early warning indicators, STI/HIV
education, promotion of family/peer communication about sexuality and HIV knowledge,
promotion of sexual abstinence and fidelity, and condom use, (Dimbuene & Defo, 2011,
Fokam et al., 2013, Njikam-Savage, 2005; Nkuo-Akenji et al., 2007). The latest global report
estimated the new cases of HIV infections among people from Cameroon all ages to 45,000
(38,000-53,000) in 2012 (UNAIDS, 2013). This report was evidence of the tremendous
preventive efforts that Cameroon has put forth to prevail the epidemic. As of 2012, the
estimated number of adults aged 15 and over living with HIV has increased from 450,000
(410,000- 490,000) in 2001 to 540,000 (500,000- 590,000) in 2012. Also, HIV prevalence
among people aged 15-49 was 4.5% (4.1%-4.9%). Unfortunately, there has been no decline
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in the number of deaths due to AIDS over the past decade. Deaths due to AIDS has risen
from 29,000 (26,000- 33,000) in 2001 to 35,000 (30,000- 40,000) (UNAIDS, 2012, 2013).
1.1.3. Cote d’Ivoire
Like Cameroon, Cote d’Ivoire has hesitated at the onset of HIV epidemic to take rigorous
measures for prevention. By the end of 2003, the estimated number of adults and children
living with HIV reached 570,000 (390,000-820,000) which led to an estimated HIV
prevalence of 7.0% (UNAIDS, 2004b). The number of deaths due to HIV was estimated to
47,000 (30,000-72,000). Despite the state of the country in ongoing civil war, efforts were
made to slow down the course of HIV infection in the general adult population. The progress
made was reflected in the 2005 estimate of HIV prevalence which was 4.7% (INS, 2006;
UNAIDS, 2006).
Despite this milestone, Cote d’Ivoire remained the country most affected by HIV in West
Africa. Since then, many prevention programs were developed to help fight HIV and bring
down the prevalence of HIV infection to the lowest level observed in many West African
countries. A variety of prevention measures were implemented including monitoring and
evaluation of sex workers, promotion of condom use and early antiretroviral therapy,
behavior change and peer-to-peer education, STI screening and treatment, universal HIV
screening, counseling and testing, care for people living with HIV, mother-to-child
transmission, promotion of sexual abstinence and late sexual debut, and voluntary HIV
testing and counseling (Anglaret et al., 2012; Jean et al., 2012; Jean et al., 2014; Koffi &
Kawahara, 2008; Ndondoki et al., 2013; Vuylsteke et al., 2012a). This achievement was
reflected in the 2008 estimates of HIV prevalence which was 3.9% (UNAIDS, 2009;
Vuylsteke et al., 2012b). According to the latest Global Report (UNAIDS, 2013), Cote
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d’Ivoire has trimmed down its adult HIV incidence by more than 50% from 2001 to 2012.
Further, the prevalence of HIV among young adults (15-24) has decreased by 42% from
2001 to 2012. As of 2012, HIV prevalence of Cote d’Ivoire is 3.2% (2.8%-3.8%).
Despite their considerable efforts in reducing the rate of HIV infection, challenges remain.
Both Cameroon and Cote d’Ivoire are still in UNAIDS’ priority list for ART coverage and
mother-to-child transmission (UNAIDS, 2013).
1.2 Statement of the Problem
Despite the striking efforts of the three countries in trimming down adult HIV prevalence
and incidence, challenges remain. HIV epidemic continues to unevenly affect the populations
of Cameroon, Cote d’Ivoire and Senegal. Reasons for this disproportionateness are multiple
and include but not limited to disparity in socio-demographic characteristics, sexual
behaviors, risky behaviors, and HIV-prevention behaviors. Scrutinizing a selected number of
these factors might help pinpoint relevant risk factors for each country to help advance
prevention efforts. Working toward effective prevention measures will help minimize HIV
prevalence and eliminate the gap between the three countries to fulfill UNAIDS’ priority
which is zero new HIV infections and zero AIDS-related deaths by 2015 and beyond.
1.3 Significance of the Study
Identifying key risk factors that contributed to differences in the prevalence of HIV
infection in Cameroon, Cote d’Ivoire and Senegal might assist in framing effective HIV
prevention programs and health policies to help close the gap and advance prevention efforts
in the three countries. Even though several studies have explored HIV risk factors in Sub
Saharan Africa, few have conducted an individual level of analysis of HIV risk factors
between Cameroon, Cote d’Ivoire and Senegal. Also, limited research has explored the
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contribution of risk factors in explaining differences in HIV prevalence between Cameroon,
Cote d’Ivoire and Senegal.
1.4 Purpose of the Study
The purpose of the study was to examine differences in HIV risk factors that contributed
to variations in the prevalence of HIV infection between Cameroon, Cote d’Ivoire, and Senegal.
To achieve this goal, the study 1) identified and compared HIV risk factors between the three
African countries 2) identified and compared the prevalence of HIV infection between the three
countries, and assessed its distribution on risk factors by gender; 3) determined risk factors that
are associated with the prevalence of HIV infection within and among countries; and 4)
identified best predictors of HIV infection and their contribution to variations in HIV prevalence
within each country. Tackling best predictive risk factors and their contribution might assist in
shaping effective prevention interventions, and therefore advancing preventive efforts in each
country to help eliminate the gap in HIV prevalence between the three countries.
1.5 Research Questions
This study explored the following questions to gain insight into risk factors that contributed
to differences in HIV prevalence between Cameroon, Cote d’Ivoire, and Senegal.
1. Are there differences in risk factors between Cameroon, Cote d’Ivoire, and Senegal?
2. Does the status of HIV infection differ between Cameroon, Cote d’Ivoire and Senegal? Is
HIV prevalence evenly distributed on risk factors by gender in each country?
3. What risk factors are associated with HIV prevalence in Cameroon, Cote d’Ivoire, and
Senegal? What risk factors are associated with HIV prevalence among the three
countries?
4. What are the best predictors for HIV infection in Cameroon, Cote d’Ivoire, and Senegal?
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To what extent do best predictive risk factors contribute to variations in HIV Prevalence
in Cameroon, Cote d’Ivoire and Senegal?

16

CHAPTER II
LITERATURE REVIEW
The aim of this study was to identify and compare HIV risk factors between Cameroon, Cote
d’Ivoire, and Senegal to understand their differences and associations with HIV status of the
three countries. Accordingly, this chapter focuses on the review of current literature including
studies that addressed HIV issues in Sub-Sahara Africa particularly in Cameroon, Cote d’Ivoire
and Senegal. The review also emphasizes risk factors that seem problematic in the three
countries. The critical role that HIV knowledge, cultural norms and social forces, and behavior
change theory play in HIV prevention efforts is also addressed.
2.1. HIV Transmission in Sub-Saharan Africa
A large body of research has documented variations in the prevalence of HIV infection
among Sub-Saharan African countries (Bingenheimer & Geronimus, 2009; Buvé et al., 2002;
Buvé et al., 2001). According to Buve et al., (2001), variations in the prevalence of HIV
infection can be related to differences in the rate of HIV spread. Factors that identify the rate of
HIV transmission in the population are complex and include sexual behavior patterns which are
defined as the probability of exposure to HIV infection, the probability of HIV transmission
defined as the odds that the transmission of the virus during sexual intercourse occurs, and the
socio-demographic factors that enhanced it. In their study of four cities in Sub-Saharan Africa,
Buvé et al. (2001) found considerable differences in the prevalence of HIV between
Eastern/Southern Africa and West/Central Africa. They indicated that variations in the
prevalence of HIV were due to differences in the rate of HIV spread. Another factor that also
explained differences in the prevalence of male circumcision
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In another study, Buve et al. (2002) found that HIV-1 epidemics that mostly occur in
Sub-Saharan Africa are due to a complex interaction of behavioral and biological factors, and
male circumcision. They indicated that sexual behavior patterns are shaped by cultural and socioeconomic contexts and that traditional gender role is central in the vulnerability of women to
HIV-1 infection. They highlighted the role of poverty, wars, and conflicts that weakened the
region and made it susceptible to the high spread of HIV-1. They suggested that prevention
strategies target gender discrimination and subordination. The authors urged law and policy
makers, community leaders, and officials to understand the real issues underlining the
susceptibility of women to HIV-1 in the region and therefore to take preventive and legal to
improve women conditions. They concluded that unless the burdens of African economic
development are solved it would remain difficult to convince young people to change their
sexual behaviors.
2.2. Gender Inequality
Gender inequality constitutes an important issue to address for effective prevention of
MTC to occur. In its last Global Report, UNAIDS (2013) pointed out that in the Sub-Saharan
region, 57% of women were living with HIV by the end of 2012. In Sub-Saharan Africa, women
were more likely to have HIV at early age than men leading to the higher HIV prevalence
observed. Also, young females were less likely to report the use of condom during their last
sexual intercourse. The report indicated that national surveys demonstrated young females aged
15-24 were more likely to have less accurate and comprehensive understanding of HIV than their
peer males of same age. Added to their lack of appropriate level of education and biological
make-up, women are subject to sex abuse and violence, and socio-economic imbalance,
inaccessibility to services that left them vulnerable to HIV acquisition. In her study, Njikam
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(2005) stated that nearly 64% of female students acknowledged taking high risk of having HIV
infection by not being able to negotiate safer sex or insist on the use of condom with men
because of their weak economic status.
2.3. HIV-related Risk Factors
2.3.1. Early Sexual Debut
Several studies have demonstrated the association between early sexual debut and an
increased likelihood of HIV infection (Peltzer, 2010; Pettifor et al., 2009; Stöckl et al., 2014;
Wand & Ramjee, 2012). Pettifor et al. (2009) investigated early sexual debut, forced sex with
first sexual partner, and lack of condom use at first sex using a national representative survey of
7,692 participants aged 15-24. The findings showed that early debut was associated with factors
that might increase the risk for HIV infection. Women and men who had had an older first sexual
partner had increased odds of HIV infection compared to those who had not. They recommended
intervention efforts that discourage early sexual debut and promote safer first sexual experience.
In another study, Wand and Ramjee (2012) conducted a follow up study on the effect of
early sexual debut and HIV seroprevalence. There were 3492 sexually active women who were
followed up on a period of three year and 1485 for a period of 2 years. The findings showed that
age at first sex, an increased number of sexual lifetime partners, and lack of high school
education and cohabitation all were associated with a potential risk of HIV infection. However,
they indicated that this association might be due to an increased number of lifetime sexual
partners. They suggested that prevention efforts be targeted towards delaying age at first sex.
Stöckl et al. (2014) conducted a systematic review of 128 full text studies with all having large
sample sizes. The final sample included 25 studies mostly cross-sectional. They found even after
adjusting for socio-demographics that there was consistently significant association between
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early sexually debut and HIV. However, the authors indicated that the increase in risk seemed
not link to behavioral factors but more to biological factors.
2.3.2. Unprotected Sex/Condom Use
There is evidence that condom use is the way to control the spread of HIV and reduce the
rate of new HIV cases. In their meta-analysis of HIV interventions for heterosexual African
Americans, Darbes et al. (2008) reviewed 35 randomized controlled trials (RCTs) studies done
from 1988 to 2005 with a total of 14, 682 participants who self reported on their HIV risk taking
behaviors. The findings showed that behavioral interventions significantly lowered participants’
willingness to engage in unprotected sex (OR= 0.75; 95% CI= 0.67, 0.84). They suggested the
promotion of condom use and safer sex negotiation. Pettifor et al. (2009) investigated early
sexual debut and associated HIV risk factors among women in South Africa. They found that the
lack of condom use at first sex was coupled with increased odds of HIV. Mostly, the lack of
condom use at first was associated with early sex debut and forced sex.
In another study on risky behaviors and condom use, Njikam-Savage (2005) investigated
university students aged 20 and older in Cameroon. She found that university students’ use of
condoms varied according to the type of relationships. More than half of the students (52.5%)
reported they used condoms with their primary partner to refrain from having STIs or unwanted
pregnancy while 23.43% of students indicated they did not because they trusted their primary
partner. Female students tended to use mixed methods, abstinence and condom depending on the
type of relationships. However, abstinence seemed more common with females aged 25-29
(40%) compared to those who were in their 30s and over (8%) and under 24 years (16%). The
concerns raised for the low use of condoms ranged from not falling for commercial profitmaking to negative perception about condom including its promotion of infidelity.
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Despite the striking progress of many countries in reducing the prevalence of HIV
infections in their countries, the 2013 Global Report indicated that many countries including
Cote d’Ivoire and Senegal have seen a decline in the use of condoms (UNAIDS 2013). In their
study, Hearst and Chen (2004) found that consistent use of male condoms by a small number of
people can have a great reduction effect on HIV spread than a larger number of individuals with
inconsistent use. However, there are variations in how people perceived the use of condoms
across countries and diverse ethnic and socio-groups (Drezin, Torres, & Daly, 2007). Therefore,
they recommended that effective promotion of condoms should find ways to address sociocultural, economic and financial, structural barriers, and legal policy challenges.
2.3.3. Multiple Sex Partners
It has been well-documented that multiple partnerships play a critical role in the spread
of HIV infection. Multiple partnering increases a partner’s risk of being infected with AIDS
virus; and is defined as a sexual relationship that involves more than one partner (Ghys, 2009;
Mah & Shelton, 2011). According to Mah & Shelton (2011), multiple partnering comes in
multiple forms including serial monogamous and concurrent sexual partnerships. In serial
monogamous, sexual partnerships do not overlap, which implies that one sexual relationship
ends while the other begins. Accordingly, newly infected person cannot transmit HIV until s/he
started another relationship. Ghys (2009) labeled this mechanism of HIV spread the “moving
forward,” In this process, the first partner is protected from getting HIV. As a result, individuals
who are engaged in serial monogamous are not potent vehicle for HIV transmission. Rather, they
are less likely to elevate the risk of their partner in getting HIV infection (Moris, 2001, Buvé,
2002, Ghys, 2009). However, if the infected individual entered a second relationship while
staying in his first one, then the first partner is at high risk of HIV infection. Because the infected
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person is moving forward and backward between both partners, it facilitates HIV spread among
his or her partners (Ghys, 2009).
The 2013 Global Report (UNAIDS, 2013) pointed out that in several countries including
Cote d’Ivoire, there is evidence of increase in risky behaviors and in the number of people who
had multiple partners. In their chapter on prevention for women, Gay et al. (2012) indicated that
multiple partnerships augmented a person’s likelihood for HIV acquisition. They reported that a
meta-analysis of 68 epidemiological studies found women with multiple partners to be three
times more likely to have HIV infection than those without multiple partners. In some countries
where HIV epidemic was generalized, many women in polygamous marriages were at high risk
of HIV acquisition (Dunkle et al; Matovu et al., 2007, Negin et al., 2009 as cited in Gay et al,
2012, p.31). In a study of 1,137 women in Kenya, Negin et al. (2009) found that women in
polygamous marriages were more likely to have HIV infection than those in monogamous
marriages (as cited in Gay et al., 2012). However, other studies on polygyny in West Africa
found no elevated risk of HIV acquisition (Reniers & Watkins, 2010; Reniers et al., 2010 as cited
in Gay et al., 2012, p.31). Gay and his colleagues suggested that in developing prevention
interventions women’s context of partnership patterns be taken into consideration.
2.3.4. Concurrent Partnerships and Cumulative Concurrent Partnerships
There is well-known evidence that much of the transmission of HIV infection occurs
through concurrent sexual partnering (UNAIDS, 2010; Buve et al, 2002; Mah & Shelton, 2011).
Concurrent sexual partnerships play a vital role in the dynamics of HIV epidemics. According to
Mah and Shelton (2011), concurrent sexual partnership is defined as any sexual relationship that
overlaps during a period of time. This includes long-term overlap sexual partnering such as
polygamy or quasi-polygamy or short term or isolated sexual partnership. Many studies indicated
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that concurrent sexual partnering increases the rate of HIV spread in the population, and
therefore may affect the prevalence of HIV infection in many African countries (Buve et al,
2002; Buve et al., 2001; Misha et al., 2009; Fishel et al, 2012; ). However, Buve et al., (2001)
indicated that the determinants of the rate of HIV transmission in the population are not simple
as previously thought and depend on conditions including sexual behavior patterns, the
probability of exposure to an infected partner, and the probability of spread of the virus during
sexual intercourse. In their study of the association between differences in the rate of HIV spread
and sexual behaviors and/or the probability of HIV spread during sexual intercourse in four
African cities, the authors found that there was considerable differences in the prevalence of HIV
between the four cities and that these differences can be explained by the differences in the rate
of HIV transmission.
However, measuring concurrency of sexual partnership is more complex than expected.
Despite the existence of theory that relates concurrent sexual partnerships to the size and rate of
HIV transmission there has been no agreement on the definition of the concept and methods of
measurement to use (Fishel et al., 2012).
In an attempt to find standardized indicators to evaluate concurrency partnerships, the
UNAIDS Reference Group came up with some approach of definition (Fishel et al, 2012, Misha
et al, 2009). According to the group, point prevalence of concurrent partnerships (primary
indicator) is the proportion of women and men age 15-49 who were engaged in ongoing sexual
intercourses with more than one ongoing sexual partnership at the point in time six months prior
to the interview. Cumulative prevalence of concurrent partnerships (alternative indicator 1) is the
proportion of women and men age 15-49 with overlapping sexual partnerships at any point in the
past. The third indicator, proportion of multiple partnerships with concurrency in the past, is the
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proportion of women and men age 15-49 with multiple sexual partnerships in the past year who
had concurrent partnerships. In their study on sexual partnerships and HIV serostatus, Misha et
al. (2009) analyzed DHS data from many countries including those in Sub-Saharan African and
found based on those definition that men were more likely to have concurrent partnerships than
women. However, they noticed that multiple partnerships reported in the last 12 months prior to
the interview, were not actually concurrent. Further, the findings showed that only limited
number of participants claimed to have overlapping partners for one year or longer.
In a similar study, and in an attempt to identify the best method that defines levels of
sexual concurrency and interpret its association with HIV infection, Fishel et al., (2012)
computed the three indicators of concurrent sexual partnerships, and then used them to examine
concurrent sexual partnership behaviors of five Central and Southern African countries. Findings
indicated that even though point of concurrent prevalence and cumulative concurrent prevalence
can be used to identify levels of concurrency, careful consideration is needed. Because of the
levels of complexity involved in the computation of concurrent sexual partnerships, one indicator
should not be considered over the other. The three indicators measure different areas of
concurrent sexual partnerships. Point of concurrent prevalence assesses long-term overlapping
sexual partnerships while the cumulative concurrent prevalence estimates the total magnitude of
overlapping sexual partnerships. The third, proportion of multiple partnerships assesses the
proportion of multiple partnerships that are concurrent in the past year. Even though theory of
concurrency supports point of prevalence as indicator the most associated with HIV infection
spread, these findings remained inconclusive.
Similarly, in their study on concurrent sexual partnerships and HIV prevalence in five
African countries, Lagarde et al. (2001) found that the prevalence of HIV infection was 1.0% in
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Dakar, Senegal, 3.4% in Cotonou (Benin), 5.9% in Yaounde (Cameroon), 25.9% in Kisumu
(Kenya), 28.4% in Ndola (Zambia). However, the proportion of sexual partnerships that were
concurrent was higher in Yaounde (0.98) than in Kisumu (0.44), Cotonou (0.33), Ndola (0.26),
and Dakar (0.18). They indicated that there was no evidence that suggested an association
between concurrent sexual partnerships and the rate of HIV spread in the five African cities.
2.4. HIV/AIDS Prevention
2.4.1. HIV/AIDS Knowledge
Understanding the basics of HIV is central for any prevention efforts. Even though the
majority of young in Sub-Saharan Africa have heard about HIV/AIDS and know about the
destructive role of HIV, many young people still hold beliefs and misconceptions about HIV
transmission and prevention (Bankole et al., 2004; Dimbuene & Defo, 2011; Njikam-Savage,
2005; Ojieabu, 2012). In her study, Njikam (2005) found that 60% of students had knowledge of
the mode of transmission of HIV/AIDS. However, 32.19% of students perceived HIV/AIDS as a
shameful disease. About 80% can correctly identify strategies for prevention. Unfortunately,
these young adults didn’t know how to translate their knowledge into protective action.
Ojieabou et al. (2012) explored the effect of educational status on HIV/AIDS knowledge,
attitude and misconceptions of pregnant women in Nigeria. They investigated 403 pregnant
women attending antenatal care at a teaching hospital in Sagamu, Nigeria. A structured
questionnaire was administered to solicit their demographic information and inquired about their
HIV/AIDS knowledge and attitudes toward people living with HIV/AIDS (PLWHA). The results
indicated that pregnant women with higher educational level had better understanding of
HIV/AIDS knowledge. The findings also pointed out that the majority of participants except
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those with no education had an average knowledge about the cause. However, there was still a
great deal of misconceptions among women with secondary education.
2.4.2. HIV Testing and Counseling
Testing for HIV infection is critical for effective prevention measures. Study showed that
testing and counseling is an effective approach to secondary prevention for HIV-positive
individuals (Matovu, 2010). Matova (2010) reviewed a number of studies about prevention
methods in discordant couples. The review focused on six interrelated behavioral HIV
prevention interventions that can be combined to lower HIV transmission risk in Sub-Saharan
Africa. The section of testing and counseling revealed that many couples in Sub-Saharan Africa
have not come together for testing or counseling nor know about each other’s HIV status. Also,
couples were not aware that HIV discordance was possible within couples. The author
recommended that behavioral interventions focus on the promotion of couples’ counseling,
testing, and disclosure. Therefore, HIV testing should be strongly recommended for anyone who
is exposed to any of the risk factors. Universal access to testing should also be promoted to
ensure all people who are sexually active and at risk know their serostatus (Ndondoki et al.,
2013; UNAIDS, 2013). Studies have demonstrated that voluntary counseling and testing can
have an adverse effect in some HIV-negative clients.
2.4.3. Male Circumcision
A large body of research has documented the protective role of male circumcision in
preventing HIV transmission. Bailey et al. (2007) conducted a randomized controlled trial (RCT)
study of 2784 men aged 18-24 in Kisumu, Kenya over a period of 24 months to assess the
protective role of male circumcision on HIV infection. 1391 men were assigned to an
intervention group (circumcision) and 1393 men to a control group (delayed circumcision). HIV
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testing, medical examinations and behavioral interviews were performed during follow-ups at 1,
3, 6, 12, 18, and 24 months. The findings indicated that the 2-year HIV incidence was 2.1%
(95% CI= 1.2, 3.0) for men who were circumcised and 4.2% (95% CI= 3.0, 5.4) for those who
had delayed circumcision. The relative risk (RR) was 0.47 (0.28, 0.72) which showed a
protective effect of 53% (22%, 72%) for HIV infection. After adjusting for non-adherence and
exclusion of 4 men, the protective effect of circumcision reached 60% (32%, 77%).
In another randomized controlled trial study, Gray et al. (2007) studied the impact of
male circumcision on HIV incidence in men. A total of 4996 uncircumcised HIV negative men
aged 15-49 were enrolled in the study. A random number of 2474 men were assigned for
immediate intervention (circumcision) while the 2522 others were placed in the control group
(delayed circumcision for 24 months). Participants were followed up with HIV testing, physical
examination and interviews at 6, 12, 24 months. The results showed over a period of 24 months
that HIV incidence among the circumcised group was RR= 0.66 per100 person-years while for
the control group RR= 1.33 per 100 person-years.
Sielgfried et al., (2009) conducted three randomized controlled trials (RCTs) in three
African countries, South Africa, Uganda, and Kenya from 2002 to 2006 to assess the impact of
male circumcision on HIV infection. Large size of participants was used for the three RCTs. But
all three trials were discontinued early due to significant outcome of the interim analyses.
Survival estimates were combined for all three trials in a meta-analysis the random effects
model. The findings indicated medical male circumcision lowers the acquisition of HIV infection
for heterosexual males by 38% to 66% over a period of a year.
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2.4.4. Cultural Norms and Social Forces
Many studies have stressed the cultural norms as factors that might facilitate the fight
against HIV and the success of Senegal in consistently maintaining low HIV prevalence in the
Sub-Saharan African region. In her study on the impact of Islam on HIV prevention among
Senegalese university students, Gilbert (2008) investigated 234 undergraduate and graduate
students from one of the national universities in Senegal. Even though the majority of students
were urban, participants were from different ethnicity and religion. The final sample after
exclusion criteria was 186 participants. The author’s hypotheses were that higher religiosity
would predict sexual abstinence, negligible experience with drug and alcohol. Because Senegal
is a polygamous society with frequent premarital relationships and because condom use is a
norm in the society, the author predicted that religion would have no effect on condom use or
multiple sexual partnerships. A 15-minutes questionnaire that included youth religiosity scale
and behavioral questions related to HIV prevention was administered. The findings supported the
hypothesis that being versed in Muslim religion significantly increases the likelihood of sexual
abstinence (OR= 1.13, p<.001). However, the findings showed that religion has no effect on the
decision of people to use condoms or drugs, or abstaining from having multiple sexual partners.
Gilbert concluded that high risk behavior taking falls beyond Islam’s influence. Therefore, she
suggested that both HIV prevention programs and the Muslim community find ways to address
the internal conflict for more successful HIV prevention.
In another study, Ansari and Gaestel (2010) explored the perceptions of religion leaders
on HIV/AIDS. A total of 87 religious leaders from various denominations were interviewed
throughout the country between May and August 2008. The findings indicated that Muslim
leaders were less likely to consider HIV/AIDS as a priority for leaders compared to Catholic or
Protestant leaders. The results also showed that religious leaders tend to teach more HIV
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prevention than recommendation for testing or educating the community for care and support for
people living with HIV/AIDS.
2.4.5. HIV Treatment as Prevention
2.4.5.1 Antiretroviral Therapy (ART) As Prevention
The World’s new vision of closing the gaps and eradicating HIV infection has speeded up
and transformed the course of HIV prevention. Advances in HIV prevention have made it
possible to consider HIV treatment as prevention and to avert the onward transmission of HIV
infection. Accordingly, several studies have investigated the effectiveness of HIV treatment as
prevention. Antiretroviral Therapy (ART) approach is found to be promising in preventing the
transmission of HIV to sexual partners or drug using partners and therefore to control HIV
epidemics. ART uses a variety of drugs to prevent viral DNA from replicating and invading the
immune system.
There are five different types of antiretroviral (ARV) drugs used in the treatment of HIV
infection (AIDS.gov, 2009). Nucleoside/Nucleotide reverse transcriptase inhibitors (NRTIs)
block the ability of HIV to use enzyme “reverse transcriptase” to regenerate new viral DNA
strands. On the other hand, non-nucleoside reverse transcriptase inhibitors (NNRTIs) act to alter
enzyme “reverse transcriptase” and prevent it from functioning properly and replicating new
copies of HIV. Protease inhibitors (PIs) interfere with enzyme protease’s ability to cut long viral
DNA strands into functional pieces for the production of new viruses. As the entry/fusion
inhibitors are concerned, they prevent HIV from entering healthy CD4 cells or bonding to them.
Finally, integrase inhibitors hinder enzyme integrase’s ability to facilitate the insertion of HIV
genetic materials into the host CD4 cells in order to generate new copies of HIV. Because of the
role that each type of antiretroviral (ARV) drugs plays in the life cycle of HIV, it is
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recommended that a combination of at least three ARV drugs from two types of ARV drugs be
taken for the effective treatment of HIV infection.
A growing body of research points out that when initiated earlier, ART could decrease
population-level incidence of HIV and death, and therefore be effective in preventing further
HIV transmission. Anglaret et al. (2012) examined two cohorts of untreated HIV infected adults
before and after availability of ART in Cote d’Ivoire. Both cohorts of 860 patients were followed
up in similar condition, under similar procedures, and by same team for 8 years. The findings
indicated that most deaths that occurred in these cohorts were due to tuberculosis and other
bacterial diseases. Therefore, they suggested better diagnosis and supported early use of ART to
reduce the incidence of opportunistic diseases and prevent death.
Cohen and colleagues (2013) examined 11 observational studies and 4 community
randomized trials and found that ART considerably trimmed down HIV transmission to sexual
partners. The randomized trials which used earlier initiation of ART in combination with
condoms and counseling decreased the spread of HIV in heterosexual serodiscordant couples by
96.4%. This means that early use of ART could slow or suppress the viral load DNA from
replicating and invading the immune system. The prevention of the viral load from expanding
could lower the level of latent viral reservoir and minimize the risk for further spread of HIV
infection to sexual partners.
Further, the examination of several natural experiment case studies in four countries
(USA, Canada, France and Australia) showed that the reductions in community viral load were
associated with the decline in new cases of HIV infection (Wilson, 2012). In France, the use of
ART led to a decrease in HIV incidence of all major population groups except men who have sex
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with men (MSM). In Canada, an association was found between a reduction in the rate of new
cases of HIV infection and the surge in the rate of testing, ART coverage, and viral suppression.
Another exploration of a number of ecological studies and a randomized controlled trial
suggests that suppressive antiretroviral therapy (ART) considerably lowers heterosexual HIV
spread in stable, monogamous and discordant couples (Smith et al., 2012). The results showed an
association between an increase use of ART and a decrease in HIV transmission. Provision of
free ART was linked with a 53% reduction in the rate of HIV transmission.
More studies have demonstrated early use of ART as a potential route for the prevention
of HIV epidemic (Boily et al., 2012; Buchbinder, 2012; Granish et al., 2009; Montaner, 2013).
Granish et al. (2009) used mathematical models to examine a strategy of universal voluntary
HIV testing and immediate treatment with ART. The study was based on representative data
from South Africa representing 17% of all people living with HIV. The study hypothesis
assumed that almost all transmission was heterosexual and intravenous drug use did not
substantially contributed to the overall rates of HIV infection. The findings showed that annual
universal voluntary HIV testing for all people older than 15 years combined with immediate
ART after diagnosis could successfully reduce HIV transmission to the point of elimination by
2020. However, the authors warned about the implementation which could be labor intensive and
overwhelmingly expensive. Also, they suggested that the approach be used in combination of
other strategies. They recommended further mathematical modeling research and consultation.
Despite evidence of success of ART treatment, challenges remain. Cohen et al. (2013)
indicated that not all individuals in their contagious stage could be located and given proper ART
treatment. Also, there is no evidence yet to support the effectiveness of ART in preventing the
spread of HIV infection with men who have sex with men (MSM) and people who inject drugs
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(PWID). Further, in real world populations, the use of ART is subject to a number of barriers
including non adherence to treatment, migration from higher HIV prevalence regions, emergence
of marginalized groups, shifts in risky behaviors, difficulties identifying patients and keeping
them in clinical care, differences in the effectiveness of ART due to variations in modes of HIV
transmission, and increased prevalence of potential transmitters (Wilson, 2012). Therefore, there
is a series of obstacles to overcome in order for ART treatment to be effective in trimming down
HIV infectiousness.
Accordingly, many recommendations have been provided concerning the early and
immediate use of ART. Cohen et al. (2013) suggest improved detection of HIV infection at all
stages and continuing evaluation of early ART to appraise the benefit of HIV treatment as
prevention. In order for treatment to be effective in controlling the HIV epidemic, the authors
also recommend that universal access to antiretroviral therapy (ART) be provided and strict
adherence to treatment be observed. In addition to the desire for universal access to ART, Wilson
(2012) proposes that adequate health-care infrastructure be available and combination prevention
approaches be used to lessen HIV incidence among all major groups. In 2013, the World Health
Organization made specific recommendations regarding the initiation of ART as treatment of
HIV infection for adolescents and adults. These recommendations has been adopted by many
countries around the world (AVERT, 2014).

2.4.5.2. Pre-Exposure Prophylaxis (PrEP)
Pre-exposure prophylaxis is a new approach to HIV prevention in which HIV negative
individuals who are highly exposed (a person with HIV positive partner, sex workers, MSM,
injection drug users) take daily HIV drugs to minimize their risk of becoming infected
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(AIDS.gov, 2013b). Accordingly, only people who do not have HIV infection but seem at high
risk are given PreEP drugs.

A number of studies have investigated the effectiveness of PreEP drugs in reducing the
risk of getting infected with HIV. Gupta et al. (2013) reviewed multiple clinical trials and
reported that the use of PreEP drugs lowered the risk of HIV infection by 44-75%. However, two
other clinical trials showed no efficacy of PreEP drugs in reducing the risk of HIV infections.
Also, there is a concern that the use of these drugs could lead to the emergence of HIV drug
resistance.
Supervie (2013) examined several clinical trials on PreEP and reported that only four of
these studies (Caprisa 004, IPrEX, Partner PrEP, and TDF-2) showed significant reduction at the
level of individuals. The Caprisa 004 clinical trial done in 2010 demonstrated that a vaginal
microbicide gel with Tenofovir (TDF) can reduce the risk of HIV infection in heterosexual
women by 39% (0.06-0.60) when used within 12 hours following a sexual intercourse. The 2010
iPrEX trial reported a reduction of the risk of getting HIV by 44% (0.15-0.63) among all
heterosexual men participants when the daily intake of Truvada was observed. This reduction
reached 92% (0.40-0.99) in men with detectable levels of the drug in their blood. In the Partner
PrEP trial conducted in 2012, the decrease in the risk of becoming infected was 75% (0.55-0.81)
among heterosexual discordant couples who took Truvada, and 67% (0.44-0.81) with couples
who used TDF. This drop off was even higher to reach 90% in couples with detectable levels of
the drug in their blood. The TDF-2 trial done in 2012 showed a reduction in the risk of being
infected by 62% (0.21-0.83) when Truvada was taken. The effect of PreEP when used at the
population level remains unclear.
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2.4.5.3. Post-Exposure Prophylaxis (PEP)
This type of ART is of short term and administered shortly after suspected exposure to AIDS
virus. PEP helps avoid seroconversion of HIV negative people to HIV infected. PEP is used
mostly to address the issue of occupational exposure. The successful implementation depends on
accurate self-identification of being exposed or being at risk of exposure, counseling on
implications for incorrect self identification, educating on the determination of exposure source
or risk, HIV testing, selection of suitable PEP regimen, administration of PEP within 72 hours of
exposure, and completion of 28-days taking of PEP (AIDSTAR-ONE, nd). There is consensus
that PEP when timely used is effective in preventing HIV transmission (Ellis et al., 2005; Siika et
al., 2009; Weber et al., 2010). Siika et al. (2009), investigated 446 patients with occupational
PEP and non-occupational PEP (nPEP) over a period of 5 years. The findings showed that those
who accurately followed the recommendations and timely completed their PEP had their HIV
test remained negative. They concluded that PEP and nPEP can be given in resource limited
settings.
2.5. Behavior Changes in HIV Epidemiology
Despite the tendency that people are naturally resistant to change, behavioral changes do
occur (Bingenheimer & Geronimus, 2009, Gay et al., 2012). In their review of literature, Gay et
al., (2012) found that HIV prevalence lowered from a high 13.4% to nearly 7% in less than 10
years in Kenya. Similar decrease of prevalence was observed in Rwanda where in less than 7
years the country aggressively brought down its high HIV prevalence from 13% to 3%. Also,
there was an increase in men’s use of condoms to estimated 75%. The 2013 Global Report
highlighted how some countries including Cote d’Ivoire had reduce their HIV prevalence to 50%
from 2001 to 2012 (UNAIDS, 2013).
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In their conceptualization of behavioral mechanisms in HIV, Bingenheimer & Geronimus
(2009) indicated that considerable reductions in HIV prevalence may be achieved by small
changes in behavior. Despite the current understanding that the control of HIV epidemics should
involve a combination of biological or biomedical (other infectious diseases, ART, male
circumcision) and behavioral mechanisms, the latter seems to bring by a large the most reduction
in HIV epidemics. According to the conceptual framework that has shaped epidemiological
thinking and research for decades, HIV transmission is an interplay of behavioral patterns (which
define the likelihood of exposure to HIV), biological process (indicates the probability that an
exposure turns to infection) and socio-demographic and biomedical factors (shapes the duration
of infectiousness).
Accordingly, some HIV epidemiologists have focused their attention to the understanding
of the biological mechanisms that govern the transmission of HIV while other group of
researchers seeks for the identification and understanding of the paths of HIV transmission and
patterns that shaped them (behavioral mechanisms). In their search for answers to the high rate of
HIV prevalence and new infections in the Sub-Saharan region, many researchers stressed
multiple partnerships, cultural practices, economic challenges, low condom use, and pre-marital
sexual intercourses as the probable elements of explanation. Others found risky behaviors to be
strongly associated with the likelihood of getting HIV. However, none of these research studies
seemed to convincing until Southern African epidemiologists demonstrated the behavioral risk
deep rooted within powerful social forces and demanded its change.
Therefore, Bingenheimer & Geronimus (2009) articulated that several claims have
supported behavioral approaches as key in prevention interventions. Also, the conceptual
framework that shaped these approaches is important for effective prevention interventions. The
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first concept, the nonlinear relationship between behavioral risk and HIV prevalence at the
population stipulates that small changes in behaviors may induce substantial reductions in HIV
prevalence. The second claim is that people can and do modify their behaviors. In light of HIV
threats, many individuals have changed their risky behaviors under the spectrum of fear when
they realized many people including some of their relatives or acquaintances died from the
infection. Also, many young adults have changed their behaviors in face of the spread of HIV
infection. Similarly, at the population level responses to changes in HIV prevalence came swiftly
when many Sub-Saharan African countries realized the threats of HIV on their population. Many
examples including those of Cote d’Ivoire, Cameroon, South Africa, and Zambia were already
emphasized. However, behavioral changes may not occur as rapidly as expected due to the
individual and collective processes that shape behaviors.
Another concept that seems very important and should not be overlooked when designing
prevention interventions is the behavior risk compensation. The model seems to undermine the
progress in reduction of HIV prevalence. When people realized that using condoms can prevent
them from getting HIV infection, they changed their behaviors by increasing their use of
condoms but engaged in sexual intercourses with multiple partners.
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CHAPTER III
METHODS AND PROCEDURES

3.1. Background
The purpose of the study was to examine and compare risk factors for HIV between three SubAfrican countries to understand their differences and association with variations in HIV
prevalence of the three countries. To achieve this goal, the study used secondary data pertaining
to Cameroon, Cote d’Ivoire, and Senegal from The Demographic and Health Surveys Program
(DHS).
3.2. Study Design and Data source
This study was a cross-sectional design and used approved datasets from DHS. The approved
datasets were from Cameroon (2011), Cote d’Ivoire (2011-2012) and Senegal (2010-2011).
Demographic and Health Surveys (DHS)- DHS is a program of the United States Agency for
International Development (USAID). DHS is funded in 1984 and for the purpose of solving
global health challenges and promoting health and population trend understanding in developing
countries. Since then DHS program has contributed to the development of more than 300 surveys
implemented in over 90 countries. The program collects and makes available upon request
accurate data that are nationally representative (DHS, 2014a).
DHS program uses three categories of core questionnaires to collect its primary data: A
household questionnaire, individual women’s questionnaire, and men’s questionnaire. Household
questionnaire was designed to gather information on characteristics of the household unit. The
questionnaire also helps generate eligible members for further individual interview using the
women’s or men’s questionnaire. Individual questionnaires collect information on a variety of
topics including marriage, reproductive health and HIV/AIDS. Often, eligible women are of
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reproductive age, which means between 15 and 49 years old whereas eligible men are 15-59
years or 15-54 depending on the country. DHS surveys gather basic demographic and health
information, and may slightly vary from one country to the other consistent with the host
country’s priority. Also, DHS program yields model questionnaires that are modified over time.
Accordingly, DHS surveys have evolved from its initial phase 1 (DHS I) to reach phase 6 (DHS
VI) of its development (DHS, 2014b). This study used DHS Phase 6.
Multiple Indicator Cluster Survey (MICS)- is an international survey program initiated by
United Nations Children’s Funds (UNICEF). The survey program assists many countries in
systematically collecting and analyzing data to produce statistically valid estimates of health
indicators and other issues relevant to women and children. The program also helps countries
monitor their national and global commitments including the Millennium Development Goals
(UNICEF, 2012).
A combined DHS and MICS (DHS-MICS) survey was administered in the three countries
between 2010 and 2012.

3.3. Study Subjects
3.3.1. Study Population
3.3.1a. Study Population of Cameroon
The DHS-MICS survey was carried out in Cameroon from January 2011 to August 2011 by the
National Institute of Statistics (INS). It was a national survey conducted at the household and
individual levels throughout the country. A total of 15,050 households were selected among
which 14,354 households occupied by 15,852 women and 7,525 men were identified and eligible
for interviews.
3.3.1b. Study Population of Cote d’Ivoire
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The DHS-MICS survey was administered from December 2011 to May 2012 by the Ministry of
Health and the Fight against AIDS in collaboration with the National Institute of Statistics (INS).
It was a national survey implemented at the household and individual levels throughout the
country. A total of 10,413 households were selected among which 9,873 households occupied by
10,848 women and 5,677 men were identified and eligible for interviews.
3.3.1c. Study Population of Senegal
The DHS-MICS survey was conducted from October 2010 to April 2011 by the National Agency
of Statistics and Demography (ANSD). It was a national survey administered at the household
and individual levels throughout the country. A total of 8,212 households were selected among
which 8,029 households occupied by 16,931 women and 5,688 men were identified and eligible
for interviews
3.3.2. Sampling Design and Study Sample of Cameroon
3.3.2a. Study Sample of Cameroon
A stratified national sample of 15,050 households was selected. The stratification was
done to provide an adequate representation of the urban and rural areas as well as the 12 domains
of study which corresponded to the 10 administrative regions.
The sampling procedure used “aréolaire” stratified two-phase cluster design (INS et ICF,
2012a). In the first stage or primary sampling unit, clusters or enumeration zones were selected
throughout the country and drawn from the 2005 General Census of Population and Housing.
Overall, 580 clusters were selected using a systematic sampling method with probability
proportional to the number of household in the enumeration zone. The chosen clusters included
291 in urban areas and 289 in rural areas. An enumeration of households was done within each
cluster which generated a list for the second-stage sampling. In the second-stage sampling, a
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systematic sampling method with equal probability was used to choose from the list of
households. All women aged 15-49, who lived in the selected households or who visited the
households the night before the interview were eligible to participate. Also, one in every two
households was selected for the men’s survey. In Total 7,525 men were eligible for the
interview. Further, all men and women who were eligible for the individual survey were also
selected for blood testing for HIV.
In sum, among the 580 clusters, 578 were successfully surveyed and two inaccessible. A
total of 15,050 households were chosen among which 14,354 households were identified for the
interview. From this pool of households, 14,214 successfully participated in the survey leading
then to 99.0% response rate. For individual interviews, 15,426 out of 15,852 women aged 15-49
and residing in the 14,214 households were successfully interviewed with a response rate of
97.3%. An overall 7191 of 7,525 eligible men aged 15-59 were also successfully interviewed
with a response rate of 95.6%.
Thus, the sample size for women aged 15-49 was 15,426 and 7191 for men aged 15-59.
This brought the total sample size to 22,617. However, this study focused on men and women
aged 15-49. The final sample size for this study was 15,426 for women and 6452 for men leading
to 21,878.
3.3.2b. Sampling Design and Study Sample of Cote d’Ivoire
A stratified national sample of 10,413 households was selected. The stratification was
done to allow an adequate representation of the urban and rural areas as well as the 11 domains
of study which corresponded to the 10 former administrative regions.
The sampling procedure used “aréolaire” stratified two-phase cluster design (INS et ICF,
2012b). In the first stage or primary sampling unit, clusters or census districts were drawn

40

throughout the country and from the 1998 General Census of Population and Housing. An update
of the clusters was made which helped generate a complete list of households for the secondphase sampling. Overall, 352 clusters including 161 urban and 191 rural were selected using a
systematic sampling with probability proportional to the number of census districts or
households. In the second-phase sampling, a systematic sampling method with equal probability
was used to select a consistent number of households. An average 27 households were selected
from each cluster in the urban area and 32 in the rural area. All women aged 15-49, who lived in
the selected households or who visited the households the night before the interview were
eligible to participate. Also, one in every two households was eligible for the men’s survey.
Further, all men and women who were eligible for the individual survey were also identified for
blood testing for HIV.
In sum, among the 352 clusters, 351 were successfully surveyed and one inaccessible. A
total of 10,413 households were chosen among which 9,873 households occupied were identified
for the interview. From this pool of households, 9,686 successfully participated in the survey
leading then to 98.1% response rate. For individual interviews, 10,060 out of 10,848 women
aged 15-49 and living in the 9,686 households were successfully interviewed with a response
rate of 92.7%. An overall 5135 of 5,677 eligible men aged 15-59 were successfully interviewed
with a response rate of 90.5%.
Thus, the sample size for women aged 15-49 was 10,060 and 5135 for men aged 15-59.
This brought the total sample size to 15,195. However, this study used data only from men and
women aged 15-49. Therefore, the final sample size for this study was 10,060 for women and
4622 for men leading to 14,682.
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3.3.2c. Sampling Design and Study Sample of Senegal
A stratified national sample of 8,232 households was selected in hopes that 15,044
women aged 15-49 and men aged 15-59 would be interviewed. The stratification was
implemented to accurately represent urban and rural areas of each region throughout the country.
The sampling procedure consisted of randomly stratified two-phase cluster design
(ANSD, 2012). In the first phase or primary sampling unit or cluster, enumeration areas were
drawn from the Census District (CD). A total of 28 sampling strata were generated with each
stratum including urban and rural sections of each region. The first-phase sample was
independently selected in each stratum. A systematic sampling method with probability
proportional to sample size was used to yield 391 clusters among which 147 clusters in urban
areas and 244 in rural areas. In the second phase, sample was independently selected within each
primary unit or cluster. An enumeration of households in each cluster generated a list of
households for the second-phase sampling. A systematic sampling method with equal probability
was used to choose from the list of households. All women aged 15-49, who lived in the selected
households or who visited the households the night before the interview were eligible to
participate. Within each cluster, 21 households were chosen for the women individual interview.
For the men’s survey, only 8 out of 21 households were selected. All men aged 15-59 living in
the selected households were eligible for interview.
Thus, 8,212 households were chosen among which 8,029 households were occupied and
identified for the interview. From this pool of households, 7,902 successfully participated in the
survey leading then to over 98.4% response rate. For individual interviews, 15,688 out of 16,931
women aged 15-49 and residing in the 7902 households were successfully interviewed with a
response rate of 92.7%. The men’s survey, which was administered in every three households,
had a success response rate of 87% (4,929 out of 5,668 eligible men aged 15-59).
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Blood samples were also collected from 5,326 women and 4,429 men. The collection of
blood for HIV testing from representative samples of men and women provided nationally
representative estimates of the rate of HIV prevalence in Senegal.
Thus, the sample size for women aged 15-49 was 15,688 and 4,929 for men aged 15-59.
This brought the total sample size to 20,617. However, this study focused on men and women
aged 15-49. The final sample size for this study was 15,688 for women and 4,414 for men
leading to 20,102.

3.3.3. Inclusion/Exclusion Criteria
This study included all eligible men and women who successfully completed their blood test for
HIV testing in each country. However, the study was limited to data of men and women aged 1549 years only.

3.4. Study Variables
3.4.1. Dependent Variables
The dependent variable is HIV status. Participants’ HIV status was diagnosed after a
voluntary blood test for HIV was done. HIV consent statement was reviewed with and approved
by each participant prior to HIV blood testing. Each country’s ethical review committee
reviewed and approved the testing protocol prior to blood testing. The testing consisted of
collecting blood spots from a finger prick onto filter paper and carried to a laboratory for testing.
The lab protocol involved an initial enzyme-linked immunosorbent assay (ELISA) test and then
retesting of all positive and 5%-10% of negative tests with a second ELISA. For discordant
results from the second ELISA, a new ELISA or Western Blot was conducted. Because of the
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anonymity of the testing, participants were not provided with their results but were offered
educational materials and referrals for free voluntary counseling and testing (VCT).
Even though individual blood test received a unique random identification number (bar
code) that could be linked to the core questionnaire file, the results of blood testing were placed
in a separated data file. Four types of HIV status emerged as the results of the blood test,
‘HIV negative,’ ‘HIV positive,’ ‘HIV2 positive,’ and “HIV1 and HIV2 positive.” For the
purpose of this study, the four categories were re-coded into two categories ‘HIV negative’ and
‘HIV positive.’

3.4.2. Independent Variables
In this study, the following 13 independent variables were explored.
Gender- Men and women were interviewed with different sets of but mostly similar
questionnaires. For women’s questionnaire, additional questions pertaining to reproductive
history, and child health and mortality were included. For the purpose of this study, only relevant
data sets were used. This study merged both datasets from men and women in order to generate
the gender variable which was coded ‘male’ and ‘female.’
Age- Respondent’s age was determined from the questions ‘in what month and year were you
born?’ and ‘how old were you at your last birthday?’ The answers for both questions were
compared and corrected if inconsistency occurred. DHS data includes two variables for age, the
current age of participant and the age in 5-year groups. This study used the variable current age
to calculate the median age but recoded the 5-year groups as ‘15-19,’ ‘20-29,’ ’30-39,’ and ‘4049.’
Educational Level- Participants were asked if they ever attended school. Those who indicated
“Yes” were followed up with a question “What is the highest level of school you attended:
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primary, secondary, or higher?” The answers were categorized into four groups: ‘No education,’
‘Primary,’ ‘Secondary’ and ‘Higher.’
Current marital status- Participants were asked the following questions to help identify their
marital status: “Are you current married or living together with a woman/man as if married?”
“What is your marital status now: are you widowed, divorced or separated?” The answers were
classified as ‘Never in union,’ ‘Married,’ ‘Living with partner,’ ‘Widowed,’ ‘Divorced,’ and ‘No
longer together/Separated.’ This study regrouped the six categories into 4: ‘Never in union,’
‘Married/Living with partner,’ ‘Widowed/Divorced,’ and ‘No longer together/Separated.’
Wealth index- To identify the wealth index, respondents were asked about assets of the
household including owning televisions and bicycles, materials for construction, types of water
access and sanitation facilities. Because the wealth index is a composite measure of a
household’s cumulative living standard, it was calculated using the statistical method of principal
components analysis. The results of the analysis were categorized into five groups ‘Poorest,’
‘Poorer,’ ‘Middle,’ ‘Richer,’ and ‘Richest.’ This study regrouped the five categories into 3:
‘Poor,’ ‘Middle,’ ‘Rich.’
Age at 1st sex- The question asked was “how old were you when you had sexual intercourse for
the very first time?” Responses were coded ‘Never had sexual intercourse,’ ‘Age in years’ and
‘First time when started living with first wife/partner.’ This study used age at first sex imputed to
eliminate inconsistency. The variable was re-coded ‘Never had sex,’ ‘Before 15,’ and ‘15+.’
Had any STI in last 12 months- The question was “During the last 12 months, have you had a
disease which you got through sexual contact?” The answer format was ‘Yes,’ ‘No,’ or ‘Don’t
know.’ The study recoded by considering the 3rd category as missing.
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Number of injections in last 12 months- The questions asked were “have you had an injection
for any reason in the last 12 months?” If subjects said ‘Yes,’ the follow-up question was “How
many injections have you had?” Responses were ‘None,’ ‘Number of injections,’ ‘90’ if 90 or
more, and ‘Don’t know.’ In this study, the outcome was regrouped into ‘None,’ ‘1-4,’ and ‘5+.’
Multiple sex partners excluding wives/husband- The question was “In total, with how many
different people have you had sexual intercourse in the last 12 months?” The response was either
‘Numerical,’ ‘Don’t know,’ or ‘95’ if more than 95. The study recoded this variable as ‘0,’ ‘1,’
‘2+.’
Total lifetime numbers of sex partners- Respondents were asked in total how many different
people they have had sexual intercourse with in their lifetime. The response format was
‘Numerical,’ ‘95’ if 95 and more, or ‘Don’t know.’ The study recoded into ‘1,’ ‘2,’ ‘3+.’
Know a place to get HIV test- The question was “Do you know a place where people can go to
get tested for the AIDS virus?” The response format was ‘Yes’ or ‘No.’
Ever been tested for HIV- The question was “Have you ever been tested to see if you have the
AIDS virus? The response format was ‘Yes’ or ‘No.’
Condom used last time had sex with most recent partner- The question was “The last time
you had sexual intercourse with the last sexual partner, was a condom used?” The response
format was ‘Yes’ or ‘No.’

3.5. Statistical Analysis
Data were managed and analyzed using IBM Statistical Package for Social Scientists (IBM
SPSS) version 21 (IBM SPSS Inc. 2012). Data from individual women’s questionnaires, men’s
questionnaire, and HIV testing results were merged using three coding identifications “Cluster
number,” “Household number” and respondent’s “Line number.” Participants aged less than 15
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years or over 49 years old were excluded from data analysis. In this study, HIV sample weight
was considered as a unit of analysis because of its association with both datasets (individual
women and men). Accordingly, HIV sample weights were applied to all cases during descriptive
analyses to make data results representative of the entire population in each country. Medians
were calculated for two independent variables (Age at first union and age at first sex) and crosstabulations were performed for frequency distributions of all selected independent variables and
the dependent variable.
Binary logistic regression including univariate and multivariate analyses was conducted
to help identify the association between selected HIV-related risk factors and HIV prevalence
within each country and among the three countries. Odds ratios and 95% confidence interval
were calculated for the univariate and multivariate logistic regression analyses. Statistical
adjustments were made for confounding variables during the multivariate analysis. Forward
Likelihood Ratio (LR) logistic regression was performed to help identify the best predictive risk
factors of HIV infection in each country and understand the proportion of variation in HIV
prevalence that could be explained by identified predictive risk factors.
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CHAPTER IV
RESULTS
The purpose of this chapter is to depict the results of data analyses as related to the
research questions. The objective of the study was to compare risk factors for HIV infection
among three African countries, Cameroon, Cote d’Ivoire and Senegal to understand their
differences; to identify factors that are associated with the prevalence of HIV infection within
and among countries; and to determine what best predictive risk factors accounted for the
variations in HIV prevalence of the three countries. Accordingly, this chapter presents the results
relevant to the study questions into four sections: 1) Descriptive analysis of HIV risk factors
between Cameroon, Cote d’Ivoire, and Senegal; 2) Descriptive analysis of HIV status of
participants among the three countries; and the distribution of HIV prevalence on risk factors by
gender in each country; 3) Binary logistic regression analysis- univariate and multivariate
analyses of the association between selected risk factors and HIV prevalence in each country and
multivariate analysis of the association between selected risk factors and HIV prevalence among
countries; and 4) Forward stepwise likelihood ratio (Forward LR) analysis of best predictors of
HIV prevalence within each country, and the contribution of best predictors to variations in HIV
prevalence of each country.
4.1. Descriptive Analysis- Differences in Risk Factors for HIV between Cameroon (2011),
Cote d’Ivoire (2011-2012), and Senegal (2010-2011)
The sample size for this study was 21,878 in Cameroon, 14,682 in Cote d’Ivoire, and 20,102 in
Senegal and was used for the regression analysis. For the descriptive analysis and for making the
results representative of the entire population, HIV sample weights were applied to the datasets
of the three countries before medians were calculated, and frequency distributions using cross-
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tabulation were explored. Accordingly, the weighted sample size was 13,503 for Cameroon,
8,560 for Cote d’Ivoire, and 9,430 for Senegal.
The results indicated significant differences (p<0.001) for all 13 variables across the three
countries (Table 1). Even though more than half of the respondents in all three countries were
females, there were significant differences in the representation across countries. A higher
proportion of females were represented in Senegal (56.5%) compared to Cameroon (53.5%) or
Cote d’Ivoire (52.7%). However, more males were represented in Cote d’Ivoire (47.3%) than in
Cameroon (46.5%) or Senegal (43.5%).
Adults aged 20-29 represented the majority of the study population in all three countries.
However, the level of participation differed from one country to another. A higher percent of
adults aged 20-29 participated in Cote d’Ivoire (37.1%) compared to Cameroon (36.8%) or
Senegal (36.6%).
Differences were more pronounced with the educational level status. In Cameroon, the
majority of respondents were those with secondary education (45.5%) followed by individuals
with primary education background (32.6%) whereas in Cote d’Ivoire and Senegal the majority
of respondents has no education (44.3%, 48.2%, respectively) followed by individuals with
primary education (26.5%, 24.8%, respectively) and those with secondary education background
(24.9%, 24.6%, respectively).
More than half of participants in all three countries were married or living with a partner;
however, a higher percent of those adults was involved in Cote d’Ivoire (56.1%) compared to
Cameroon (54.8%) and Senegal (53.0%). The second majority of participants were ‘never in
union’ adults with the highest proportion being in Senegal (43.8%) followed by those in Cote
d’Ivoire (38.6%) and Cameroon (38.4%).
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Interestingly, in the area of wealth index, the results showed that the majority of
participants were rich in all three countries. However, there were differences between the levels
of representation. More rich people (48.3%) were represented in Cameroon than in Senegal
(47.6%) and Cote d’Ivoire (45.9%).
As shown in the table, the median age at first sex was similar in Cameroon (16 years) and Cote

d’Ivoire (16 years) but lower in Senegal (15 years). However, the proportion of men and women
who reported having their first sexual intercourse before the age of 15 was significantly (p<.001)
higher in Cote d’Ivoire (17.4%) than in Cameroon (15.2%) and Senegal (11.0%). In Senegal, few
participants (1.0%) reported having sexually transmitted infection (STI) in the last 12 months
compared to those in Cameroon (4.2%) and Cote d’Ivoire (5.6%). Respondents who indicated
they had received 5 and more injections in the last 12 months were significantly (p<.001) higher
in Cameroon (10.8%) than in Cote d’Ivoire (5.7%) and Senegal (3.7%).
The proportion of men and women who claimed they had one partner in addition to their
wife/husband was significantly (p<.001) higher in Cote d’Ivoire (24.2%) than in Cameroon
(22.4%) or Senegal (8.1%). However, those who stated they had 2 and more sexual partners
besides their spouse were similarly higher in both Cameroon (9.5%) and Cote d’Ivoire (9.3%)
than in Senegal (1.4%). This last claim was consistent with the corresponding results of total
lifetime numbers of sex partners. The percentage of adults who indicated they had 3 and more
total lifetime sexual partners was significantly (p<.001) higher in Cameroon (58.0%) and Cote
d’Ivoire (53.7%) than in Senegal (21.7%).
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Table 1 Differences in Characteristics of Participants/Risk Factors between Cameroon
(2011), Cote d'Ivoire (2011-2012, and Senegal (2010-2011)
Characteristics
Cameroon
Cote d’Ivoire
Senegal
p-value
______________ _____________ _____________
N
%
N
%
N
%
Gender
<.001*
Male
6282
46.5
4051
47.3
4104
43.5
Female
7221
53.5
4509
52.7
5326
56.5
Age
<.001*
15-19
3198
23.7
1754
20.5
2311
24.5
20-29
4968
36.8
3172
37.1
3447
36.6
30-39
3203
23.7
2268
26.5
2218
23.5
40-49
2134
15.8
1366
16
1454
15.4
Educational level
<.001*
No education
2006
14.9
3796
44.3
4546
48.2
Primary
4407
32.6
2266
26.5
2341
24.8
Secondary
6148
45.5
2129
24.9
2316
24.6
Higher
943
7.0
369
4.3
226
2.4
Current marital status
<.001*
Never in union
5191
38.4
3303
38.6
4134
43.8
Married/Living with
7401
54.8
4798
56.1
4996
53
a partner
Widowed/Divorced
396
2.9
173
2
255
2.7
Separated/No longer
515
3.8
286
3.3
45
0.5
living together
Wealth index
<.001*
Poor
4423
32.8
3065
35.8
3008
31.9
Middle
2555
18.9
1562
18.3
1934
20.5
Rich
6526
48.3
3933
45.9
4488
47.6
Median age at first sex
16 years
16 years
15 years
Age at first sex
<.001*
Not had sex
2179
16.7
946
11.6
2762
30.4
Before 15
1985
15.2
1424
17.4
1001
11
15+
8856
68
5819
71.1
5308
58.5
STI in last 12 months
<.001*
No
12831
95.8
8041
94.4
9333
99
Yes
556
4.2
477
5.6
92
1
Number of injections
<.001*
in last 12 months
None
7953
58.9
5209
60.9
6332
67.3
1-4
4083
30.3
2864
33.5
2735
29.1
5+
1460
10.8
485
5.7
346
3.7
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Characteristics

Multiple sex partners
in last 12 months
0
1
2+
Total lifetime numbers
of sex partners
1
2
3+
Know a place to get HIV
test
No
Yes
Ever been tested for HIV
No
Yes
Condom used last time
had sex with most recent
partner
No
Yes
*p<.05

Cameroon
______________
N
%

9176
3024
1280

Cote d’Ivoire
_____________
N
%

68.1
22.4
9.5

5687
2064
796

66.5
24.2
9.3

Senegal p-value
_____________
N
%
<.001*
8541
762
128

90.6
8.1
1.4
<.001*

2847
1813
6437

25.7
16.3
58

1986
1455
3997

26.7
19.6
53.7

3808
1168
1377

59.9
18.4
21.7

1640
11410

12.6
87.4

2926
5274

35.7
64.3

2851
6225

31.4
68.6

<.001*

<.001*
6858
6562

51.1
48.9

5771
2724

67.9
32.1

7061
2369

74.9
25.1
<.001*

7336
2770

72.6
27.4

5200
1490

77.7
22.3

4841
587

89.2
10.8

The results also indicated that a significantly (p<.001) higher percent of respondents in
Cameroon reported to know a place to get tested for HIV (87.4%) than that in Senegal (68.6%)
and Cote d’Ivoire (64.3%). However, only less than half of those participants across all three
countries expressed they had ever been tested for HIV or used condoms last time they had sex
with the most recent partner. The percentage of people who agreed to either such statement was
significantly (p<.001) lower in Senegal (25.1%; 10.8%, respectively) than in Cote d’Ivoire
(32.1%; 22.3%, respectively) or Cameroon (48.9%; 27.4%, respectively).
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4.2 Differences in HIV Status among Countries and Distribution of HIV Prevalence on risk
factors by Gender within Countries
This section provides answers to the study question #2. The section consists of two parts:
Comparison of HIV status among the three countries and the distribution of HIV prevalence on
risk factors by gender in each country.

4.2.1. Differences in HIV Status between Cameroon (2011), Cote d’Ivoire (2011-2012), and
Senegal (2010-2011)
Table 2 displays the HIV status of participants aged 15-49 among countries. The results
indicated that there was statistically significant differences (p<.001) between the three countries’
HIV status. As expected, Senegal has the lowest HIV prevalence with only 0.7% of its adults
aged 15-49 being HIV positive. The country with the highest HIV prevalence is Cameroon
(4.3%) followed by Cote d’Ivoire (3.7%).

Table 2 Differences in HIV status between Cameroon (2011), Cote d'Ivoire (2011-2012),
and Senegal (2010-2011)
Variable
Cameroon
Cote d'Ivoire
Senegal
p-value
____________
____________
_______
N
%
N
%
N
%
HIV Serostatus
<.001*
HIV negative

12917

95.7

8241

96.3

9367

99.3

HIV positive

584

4.3

317

3.7

63

0.7

p<.05
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4.2.2. Differences in the Distribution of HIV prevalence on risk factors by Gender in
Cameroon, Cote d’Ivoire and Senegal
Table 3 depicts the distribution of HIV prevalence among men and women in relationship
with risk factors in Cameroon, Cote d’Ivoire, and Senegal. As shown in the table, the prevalence
of HIV infection was unequally distributed by gender in each country. The results indicated that
in Cameroon, the prevalence of HIV infection among women (5.6%) was almost twice that of
men (2.9%) whereas in Cote d’Ivoire and Senegal, the prevalence of HIV among women (4.6%;
0.8%, respectively) were one and a half times higher than that of men (2.7%; 0.5, respectively).
In Cameroon, HIV prevalence was significantly and unevenly distributed among men (pvalues vary) and women (p<.001) on 9 out of the 13 selected risk factors. Men and women aged
30 and over were the most affected by HIV infection. However, the highest prevalence of HIV
was observed among women aged 30-39 (8.6%) compared to men (5.6%). A higher HIV
prevalence was seen among women with primary education (6.7%) or secondary education
(6.3%) compared to their fellow men (3.1%; 2.5%, respectively). However, those who were the
most affected by HIV were men with higher education background (5%). A greater HIV
prevalence was recorded among women widowed and divorced (16.5%) or separated and no
longer living together (16.3%) compared to their fellow men (6.5%; 5.1%, respectively). Also,
more infected women were among rich people (6.8%) or middle class (5.8%) than men (3.3%;
2.6%, respectively) were. However, the distribution of HIV prevalence among men’s wealth
status was not statistically significant.
Further, in Cameroon, the prevalence of HIV was higher among women who had their
first sex before the age of 15 (7.2%) than fellow men who did (4.4%). Also, HIV prevalence was
noticeably higher among women who claimed to have STI during the last 12 months (11.5%)
than their fellow men did (7.1%). A higher percent of infected women (8.2%) indicated they
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received 5 and more injections in the last 12 months compared to their peer men (7.2%). Further,
the prevalence of HIV was higher among women with one extra sexual partner (8.2%) or two
extra sexual partners (8.0%) than among men with similar multiple sexual partners (3.2%; 2.7%
respectively). However, the distribution of HIV prevalence among men with multiple sexual
partners was not statistically significant. An even greater HIV prevalence (10.3%) was observed
among women with 3 and more lifetime number of sexual partners compared to men with similar
risky behaviors (3.9%). The prevalence of HIV was higher among women who reported they
knew a place to get HIV test (6.3%) or had ever been tested for HIV (7.6%) than men with
similar agreement (3.1%; 4.7%, respectively). Even though the distribution of HIV prevalence
among men and women regarding their use of condom differed, the difference was not
statistically significant.
In Cote d’Ivoire, the distribution of HIV infection among men and women was
statistically significant with 7 out of the 13 risk factors. Even though there were differences in
the distribution of HIV prevalence among men and women on educational level, STI in last 12
months, multiple sexual partners in last 12 months, and condom use with most recent sexual
partner, the differences were not statistically significant. In the area of wealth and number of
injections, the distribution of HIV prevalence was significant among men but not among women.
Like Cameroon, in Cote d’Ivoire, men and women in their thirties’ and over were the
most significantly (p<.001) affected by HIV infection. However, the highest prevalence of HIV
was observed among women aged 40-49 (7.6%) compared to men (5.0%). A greater HIV
prevalence was recorded among women widowed and divorced (17.3%) compared to their peer
men (7.5%). Further, in Cote d’Ivoire, the prevalence of HIV was slightly lower among women
who had sex before the age of 15 (4.4%) than women who had at 15 and over (4.9%). However,
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a higher percentage of women who had their first sex before the age of 15 years were HIV
positive (4.4%) than their fellow men were (3.1%). A higher percent of infected men (5.2%)
indicated they had received 5 and more injections in the last 12 months compared to their peer
who did not (1.9%). A greater HIV prevalence (7.3%) was observed among women with 3 and
more total lifetime number of sexual partners compared to men with similar risky behaviors
(3.6%). Further, the prevalence of HIV was higher among women who indicated they knew a
place to get HIV test (5.8%) or had ever been tested for HIV (6.2%) than men with similar
agreement (3.4%; 4.8%, respectively).
In Senegal, the distribution of HIV prevalence among men and women was statistically
significant with only 5 out of the 13 risk factors. Even though there were differences in the
distribution of HIV prevalence among men and women on STI in last 12 months, number of
injections, knowledge of place to get tested for HIV, ever been tested, and condom used with
most recent partner, the differences were not statistically significant. In the area of wealth, the
distribution of HIV prevalence was significant among women while it was not among men.
However, for multiple sexual partner behavior, the distribution of HIV prevalence was
significant among men while it was not among women.
Like Cameroon and Cote d’Ivoire, in Senegal, men and women in their thirties’ and over
were significantly (p<.001) the most affected by HIV infection. However, the highest prevalence
of HIV was observed among women aged 40-49 (1.9%) compared to fellow men (1.3%). A
higher HIV prevalence was found among women with primary education (1.2%) or no education
(1.0%) compared to their fellow men (0.1%; 0.9%, respectively). However, the group the most
touched by HIV among men was those with no education (0.9%). A greater HIV prevalence was
observed among women widowed and divorced (4.0%) compared to their peer men (1.9%).
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Also, women with poor wealth index status had higher HIV prevalence (1.2%) than their fellow
women with middle or rich wealth index status (0.8%; 0.5%, respectively).
Further, the prevalence of HIV was higher among women who had their first sex before
the age of 15 (1.7%) than among fellow men (0%). Men who claimed they had two extra
partners besides their wife had significantly (p<.001) higher HIV prevalence (2.5%) than men
who had only their wife as sex partner (0.3%). A greater HIV prevalence (4.0%) was also
observed among women with 3 and more total lifetime number of sexual partners than among
men with similar risky behavior (1.2%).
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Table 3 Differences in the Distribution of HIV Prevalence on Risk Factors by Gender (2011),
Cote d’Ivoire (2011-2012) and Senegal (2010-2011)
Variable
Male
Female
Cameroon Cote d’Ivoire Senegal Cameroon Cote d’Ivoire Senegal
%
%
%
%
%
%
p-value
p-value p-value
p-value
p-value
p-value
**Gender
2.9
2.7
0.5
5.6 <.001* 4.6 <.001*
0.8<.001*
Age
<.001*
<.001* <.001*
<.001*
<.001*
<.001*
15-19
0.4
0.1
0.0
2.1
0.8
0.2
20-29
1.7
0.8
0.3
5.3
4.6
0.6
30-39
5.6
3.7
0.7
8.6
6.2
1.1
40-49
5.4
5
1.3
6.7
7.6
1.9
Educational level
<.004*
=.563 =.006*
<.001*
=.053
=.017*
No education
1.8
2.9
0.9
2.8
5
1
Primary
3.1
3
0.1
6.7
4.9
1.2
Secondary
2.5
2.5
0.3
6.3
3.7
0.1
Higher
5
1.5
0.0
4.1
0.0
0.0
<.001*
<.001*
<.001*
<.001*
<.001*
<.001*
Current marital
status
Never in union
1
0.7
0.2
2.1
2.9
0.4
Married/Living
with a partner
4.6
4.5
1
5.3
4.7
0.8
Widowed/Divorced 6.5
7.5
1.9
6.5
17.3
4.0
Separated/No
longer living
together
5.1
3.1
0.0
6.3
6.3
0.0
=.114
=.043*
=.106
<.001*
=.079
=.041*
Wealth index
Poor
2.4
2.5
0.7
3.8
3.9
1.2
Middle
2.6
1.5
0.1
5.8
4.1
0.8
Rich
3.3
3.3
0.4
6.8
5.4
0.5
<.001*
<.001*
=.007
<.001*
=.002*
=.004*
Age at first sex
Not had sex
0.3
0.0
0.1
1.0
0.8
0.4
Before 15
4.4
3.1
0.0
7.2
4.4
1.7
15+
3.4
3.2
0.7
6.0
4.6
0.8
<.001*
<.551
=.749
<.001*
=.210
=.056
STI in last 12
months
No
2.7
2.8
0.4
5.3
4.4
0.8
Yes
7.1
2.1
0.0
1.5
6.0
2.9
<.001*
=.008*
=.437
=.001*
=.072
=.496
Number of
injections
in last 12 months
None
1.9
2.2
0.4
4.9
4.2
0.8
1-4
3.8
3.1
0.7
5.8
4.9
0.8
5+
7.2
5.2
0.6
8.2
7.6
1.6
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Variable

Male
Female
Cameroon Cote d’Ivoire Senegal Cameroon Cote d’Ivoire Senegal
%
%
%
%
%
%
p-value
p-value p-value
p-value
p-value
p-value

=.624
=.064
<.001*
<.001*
=.168
=.315
Multiple sexual
partners in last 12
months
0
2.8
3
0.3
4.9
4.3
0.8
1
3.2
2.7
1
8.2
5.7
1.9
2+
2.7
1.4
2.5
8
4.5
0.0
<.001*
=.001*
=.042*
<.001*
<.001*
<.001*
Total lifetime
number of sexual
partners
1
1.7
0.6
0.1
2.1
2.5
0.6
2
1.1
1.5
0.7
4.5
5.7
2.1
3+
3.9
3.6
1.2
10.3
7.3
4
=.003*
=.004*
=.830
<.001*
<.001*
=.865
Know a place to get
HIV test
No
1.1
1.8
0.4
2.2
3
0.9
Yes
3.1
3.4
0.5
6.3
5.8
0.8
<.001*
<.001*
=.373
<.001*
<.001*
=.809
Ever been tested
for HIV
No
1.5
2
0.4
3.2
3.7
0.8
Yes
4.7
4.8
0.6
7.6
6.2
0.9
=.078
=.003*
=.941
=.727
=.387
=.313
Condom used last
time had sex with
most recent partner
No
3.9
3.6
0.9
6
5
0.9
Yes
2.9
1.7
0.8
6.3
5.9
1.8
**Distribution of HIV prevalence on gender was done by country; p-values for the differences
are displayed near women’s HIV prevalence
*p<.05

4.2 Binary Logistic Regression Analysis of the Association between Selected Risk Factors
and HIV Status in Cameroon, Cote d’Ivoire and Senegal
Results of the binary logistic regression analysis helped answer the study question #3 and are
presented in three sections. The first section depicts the results of the univariate logistic
regression analysis of the association between selected risk factors and HIV prevalence in each
country; the second section covers the results of the multivariate analysis of the association
between selected risk factors and HIV prevalence in each country; and the third section presents
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the results of the multivariate analysis of the association between selected risk factors and HIV
prevalence among countries.
4.3. 1. Univariate Analysis of the Association between Selected Risk Factors and HIV
Status in Cameroon, Cote d’Ivoire and Senegal
In Cameroon, the results of the univariate analysis showed 12 out of 13 selected risk factors as
significantly associated with increased odds of HIV infection (Table 4). Only one risk factor,
‘condom used last time with most recent partner’ was significantly (p=.004) associated with
reduced odds of HIV infection. As shown in the table, women were 2.03 times (OR=2.03; 95%
CI= 1.70, 2.41; p<.001) more likely to have HIV infection compared to their fellow men. Adults
aged 20 and over were also significantly (p<.001) associated with increased likelihood of HIV
infection with the greatest increased odds being among people aged 30-39 (OR= 6.56; 95% CI=
4.66, 9.24; p<.001). Women and men with primary or secondary education background were
significantly associated with increased odds of HIV infection (OR= 1.91; 95% CI=1.42, 2.56;
p<.001 and OR= 1.52; 95% CI= 1.13-2.03; p=.005, respectively) compared to their counterparts
with no education. Being in union or having been previously in union was also considered a risk
factor for HIV infection with the greatest odds of HIV prevalence observed among widowed or
divorced men and women (OR=9.47; 95% CI= 6.74, 13.30; p<0.001). Rich men and women
were significantly associated with an increased prevalence of HIV infection (OR= 1.28; 95%
CI= 1.06, 1.54; p<.011).
The results showed that adults who had their first sexual intercourse at early age (before
15) were at greater odds of being infected with HIV (OR=11.30; 95% CI= 6.38, 20.00; p<.001)
than their peers who never had sex. Those who had STI in the last 12 months were 2.18 times
more likely (OR= 2.18; 95% CI= 1.61, 2.95; p<.001) to have HIV infection compared to their
fellows without STI infection. Men and women who reported having received injections in the
60

last 12 months were also associated with increased likelihood of HIV infection with the highest
odds (OR= 2.39; 95% CI= 1.92, 2.98; p<.001) being among those who had received 5 and more
shots.
Further, adults who were engaged in sexual intercourses with a partner other than their
wife or husband were found to be significantly associated with increased odds of HIV infection
(OR=1.26; 95% CI= 1.05, 1.51; p=.015). Also, men and women who had more than their wife or
husband as lifetime sexual partners were significantly associated with increased odds of HIV
infection with the greatest odds being among those with 3 and more lifetime sexual partners
(OR=3.14; 95% CI= 2.40, 4.10; p<.001). Men and women who claimed to know a place to get
HIV test (OR=2.40; 95% CI= 1.70, 3.39; p<.001) or have ever been tested (OR= 2.58; 95% CI=
2.17, 3.08; p<.001) were significantly associated with increased odds of HIV infection compared
to their fellows who opposed it. However, those who indicated they used condom last time with
their most recent partner were less likely to be associated with HIV infection (OR=0.73; 95%
CI= 0.59, 0.91; p=.004)
In Cote d’Ivoire, the results of the univariate logistic analysis presented 9 out of 13 risk
factors as significantly associated with increased likelihood of HIV infection (Table 4.3.1).
‘Multiple sex partners in the last 12 months’ (OR=0.45; 95% CI= 0.25, 0.81; p=.008) and
‘condom used last time with most recent partner’ (OR=0.67; 95% CI= 0.48, 0.94; p=.022) were
found as protective factors against HIV infection. As shown in the table, women were 1.81 times
(OR= 1.81; 95% CI= 1.42, 2.31; p<.001) more likely to have HIV infection than their fellow
men. Adults aged 20 and over were significantly associated with increases in the likelihood of
HIV infection with the greatest odds ratio recorded among individuals aged 40--49 (OR= 16.52;
95% CI=8.01, 34.07; p<.001).
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The results of the unadjusted logistic regression analysis also suggested that in Cote
d’Ivoire, being married or having previously been married was considered a risk factor for HIV
infection with the greatest odds observed among widowed or divorced men and women (OR=
11.04; 95% CI=6.69, 18.23; p<.001). As shown in the table, wealthy men and women had 40%
increased odds (OR= 1.40; 95% CI= 1.09, 1.81; p=.010) of being HIV positive compared to their
fellows with poor wealth index. Men and women who reported having their first sex before 15 were
significantly at greater odds of being HIV positive (OR=20.55; 95% CI= 5.01, 84.30; p<.001)
than those who never had sex. Adults who indicated they had received 5 and more injections
during the last 12 months had 123% higher odds (OR= 2.23; 95% CI= 1.50, 3.34; p<.001) of
being infected with HIV than their fellows with no shots.
Further, having more than one lifetime sexual partner or having one lifetime sexual
partner in addition to one’s wife or husband was significantly associated with increased odds of
HIV infection. The greatest odds was being among men and women with 3 and more lifetime
sexual partners (OR=2.27; 95% CI= 1.65, 3.14; p<.001) compared to those with only one
lifetime partner. Men and women who reported they knew a place to get AIDS test or had ever
been tested for HIV showed significant association with increased likelihood of HIV infection
(OR=2.36; 95% CI= 1.78, 3.13; p<.001 and OR=2.44; 95% CI= 1.94, 3.06; p<.001,
respectively).
In Senegal, the results of the univariate analysis showed 7 out of 13 risk factors to be
significantly associated with increased likelihood of HIV infection (Table 4.3.1). On the other
hand, ‘educational level’ (OR=0.22, 95% CI= 0.09, 0.51; p<.001) and ‘wealth index’ (OR=0.48;
95% CI= 0.27, 0.83; p=0.008) were highlighted as protective factors against HIV infection.
Women were 1.85 times (OR= 1.85; 95% CI=1.14, 2.99; p=.013) more likely to have HIV
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infection than men. Adults in their twenties and over were associated with an increased HIV
prevalence with the greatest increased odds found among people aged 40-49 (OR= 10.54; 95%
CI=4.09, 27.16; p<.001). Further, widowed or divorced men and women were the most
significantly associated with increased odds of HIV infection (OR=15.44; 95% CI= 6.63, 35.96).
Adults who indicated they had their first sexual intercourse before 15 were significantly
associated with the greatest increased odds of HIV infection (OR=9.06; 95% CI= 3.39, 24.20;
p<.001). Those who reported they had had STI in the last 12 months were associated with an
increase in the odds of HIV infection (OR=5.27; 95% CI= 1.89, 14.71; p<.001). Further, men
and women who had received 5 and more injections during the last 12 months had 156% higher
odds (OR= 2.56; 95% CI= 1.09, 6.02; p=.031) of being HIV positive compared to their peers
with no injections. Having more than one lifetime sexual partner or one additional lifetime
sexual partner beside one’s wife or husband was significantly associated with increased
likelihood of HIV infection with the greatest odds being among individuals with 3 and more
lifetime sexual partners (OR=2.59; 95% CI= 1.54, 4.35; p<.001).
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Table 4 Univariate analysis of the association between selected risk factors and HIV status in
Cameroon (2011), Cote d'Ivoire (2011-2012), and Senegal (2010-2011)
Variable
OR

Cameroon
95% CI
p-value

OR

Cote d'Ivoire
95% CI
p-valu

OR

Senegal
95% CI

p-value

1.00
2.03

1.70-2.41

<.001*

1.00
1.81

1.42-2.31

<.001*

1.00
1.85

1.14-2.99

=.013*

1.00
3.62

2.56-5.11

<.001*

1.00
6.19

2.99-12.80

<.001*

1.00
2.93

1.10-7.82

=.032*

30-39

6.56

4.66-9.24

<.001*

11.73

5.71-24.09

<.001*

6.50

2.51-16.87

<.001*

40-49
Educational
level
No education
Primary
Secondary
Higher
Current
marital status
Never in
union
Married/
Living with a
partner
Widowed/
Divorced
Separated
No longer
living
together
Wealth index
Poor
Middle
Rich
Age at first
sex
Never had
sex
Before 15
15+
STI in last 12
months
No
Yes

5.73

4.00- 8.19

<.001*

16.52

8.01-34.07

<.001*

10.54

4.09-27.16

<.001*

<.001*
=.005*
=.172

1.00
1.00
0.77
0.58

=.976
=.090
=.160

1.00
0.64
0.22
0.57

0.37-1.10
0.09-0.51
0.08-4.18

=.108
<.001*
=.584

Gender
Male
Female
Age
15-19
20-29

1.00
1.91
1.52
1.36

1.42-2.56
1.13-2.03
0.87-2.12

1.00

0.76-1.31
0.57-1.04
0.27-1.24

1.00

3.13

2.49-3.92

9.47

2.96

2.17-4.03

<.001*

4.25

2.24-8.08

<.001*

6.74-13.30 <.001*

11.04

6.69-18.23

<.001*

15.44

6.63-35.96

<.001*

7.10

5.06-9.95

<.001*

4.66

2.65-8.21

<.001*

0.00

0.00-..

=.998

1.00
1.24
1.28

0.99-1.55
1.06-1.54

=.064
=.011*

1.00
0.98
1.40

0.70-1.38
1.09-1.81

=.926
=.010*

1.00
0.59
0.48

0.34-1.03
0.27-0.83

=.065
=.008*

1.00
11.30
8.26

6.38-20.00 <001*
4.75-14.36 <001*

1.00
20.55
18.75

5.01-84.30
4.65-75.58

<001*
<.001*

1.00
9.06
4.99

3.39-24.20
1.99-12.50

<.001*
=.001

1.61-2.95

1.00
1.34

=.211

1.00
5.27

1.89-14.71

=.001*

1.00
2.18

<.001*

1.00

<.001

0.85-2.10
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Variable

Cameroon
95% CI
p-value

OR

Cote d'Ivoire
95% CI
p-valu

OR

Senegal
95% CI

p-value

1.00
1.47
2.39

<.001*
<.001*

1.00
1.27
2.23

0.99-1.62
1.50-3.34

=.058
<.001*

1.00
1.30
2.56

1.23-1.76
1.92-2.98

0.82-2.07
1.09-6.02

=.266
=.031*

1.00
1.26
0.91

1.05-1.51
0.68-1.23

=.015*
=.544

1.00
1.00
0.45

0.77-1.31
0.25-0.81

0.992
=.008*

1.00
1.49
1.67

0.79-2.82
0.45-6.88

=.221
=.477

1.00
1.61
3.14

1.13-2.29
2.40-4.10

.008*
<.001*

1.00
1.82
2.27

1.24-2.68
1.65-3.14

=.002*
<.001*

1.00
2.40
2.59

1.38-4.18
1.54-4.35

=.002*
<.001*

1.00
2.40

1.70-3.39

<.001*

1.00
2.36

1.78-3.13

<.001*

1.00
1.15

0.72-1.85

=.560

1.00
2.58

2.17-3.08

<.001*

1.00
2.44

1.94-3.06

<.001*

1.00
1.26

0.79-2.02

=.333

1.00
0.73

0.59-0.91

=.004

1.00
0.67

0.48-0.94

=.022*

1.00
0.93

0.42-2.05

=.858

OR
Number of
injections in
last 12
months
None
1-4
5+
Multiple sex
partners in
last 12
months
0
1
2+
Total lifetime
numbers of
sex partners
1
2
3+
Know a place
to get HIV
test
No
Yes
Ever been
tested for
HIV
No
Yes
Condom used
last time had
sex with most
recent partner
No
Yes

*p<.05

4.3.2. Multivariate Analysis of the Association between Selected Risk Factors and HIV
Status in Cameroon, Cote d’Ivoire and Senegal
In Cameroon, after adjusting for all the other variables, only 5 out of 12 risk factors
including gender, age, current marital status, number of injections in the last 12 months, and total
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lifetime numbers of sex partners remained significantly associated with increased odds of HIV
infection (Table 5). On the other hand, after controlling for the other risk factors, ‘age at first
sex’ emerged as a protective factor against HIV infection (OR=0.71; 95% CI= 0.56, 0.89;
p=.003).
In Cote d’Ivoire, after controlling for all the other variables, 7 out of 9 risk factors
including gender, age, current marital status, wealth index, number of injections in the last 12
months, total lifetime number of sexual partners, and know a place to get AIDS test were still
demonstrated significant association with increased likelihood of HIV infection (Table 4.3.2) .
One factor, ‘educational level’ appeared as a protective factor against HIV infection with the
greatest reduction in the odds of HIV being among men and women with higher education
background (OR=0.30; 95% CI= 0.12, 0.78; p=.014).
In Senegal, after adjusting for all the other variables, only 3 out of 7 risk factors, gender,
age, number of injections in the last 12 months, and total lifetime number of sexual partners
stayed significantly associated with increased odds of HIV infection (Table 4.3.2). After
adjusting for all the other variables, only women (OR=2.69; 95% CI= 1.25, 5.80; p=.012), or
those who had received 5 and more injections in the last 12 months (OR=3.14; 95% CI= 1.27,
7.75; p=.013), or who had one or more lifetime sexual partners beside their wife/husband
(OR=2.89; 95% CI= 1.33, 6.28; p=.007) were significantly associated with increased odds of
HIV infection.
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Table 5 Multivariate analysis of the association between selected risk factors and HIV status
in Cameroon (2011), Cote d’Ivoire (2011-2012), and Senegal (2010-2011)
Variable
Male
Female
Age
15-19
20-29
30-39
40-49
Educational level
No education
Primary
Secondary
Higher
Current marital
status
Never in union
Married/Living
with a partner
Widowed/
Divorced
Separated/No
longer living
together
Wealth index
Poor
Middle
Rich
Age at first sex
Never had sex
Before 15
15+
STI in last 12
months
No
Yes
Number of
injections in last
12 months
None
1-4
5+

1.71-2.68

<.001*

Cote d'Ivoire
OR 95% CI
1.00
2.35 1.67-3.32

1.00
1.72
2.18
2.13

1.08-2.73
1.35-3.54
1.28-3.53

=.022*
=.002*
=.004*

1.00
2.67
4.84
7.00

1.00
1.31
1.14
0.96

0.90-1.91
0.76-1.72
0.54-1.71

=.164
=.521
=.894

1.00
0.81
0.63
0.30

OR
1.00
2.14

Cameroon
95% CI
p-value

1.00

<.001*

Senegal
OR 95% CI
1.00
2.69 1.25-5.80

1.12-6.36
1.98-11.86
2.80-17.49

=.027*
=.001*
<.001*

1.00
1.05
1.53
1.88

0.29-3.81
0.41-5.65
0.49-7.23

=.945
=.526
=.358

0.58-1.13
0.42-0.95
0.12-0.78

=.217
=.027*
=.014*

1.00
0.66
0.28
0.00

0.32-1.38
0.08-1.01
0.00-

=.270
=.052
=.997

p-value

1.00

p-value
=.012*

1.00

1.71

1.18-2.48

=.005*

1.42

0.79-2.54

=.243

0.86

0.20-3.76

=.839

3.68

2.21-6.13

<.001*

3.10

1.40-6.88

=.005*

1.68

0.37-7.54

=.498

2.70

1.73-4.22

<.001*

0.89

0.38-2.09

=.783

0.00

0.00-..

=.999

71-1.22
0.80-1.32

=.597
=.840

1.00
1.05
1.51

0.70-1.58
1.09-2.07

=.813
=.012

1.00
0.58
0.63

0.28-1.21
0.30-1.31

=.144
=.214

…

…

0.32-5.96
0.33-5.94

=.671
=.645

1.00
1.15
0.77

0.24-5.46
0.17-3.46

=.864
=.729

1.00
0.93
1.03
..
1
0.71

0.56-0.89

=.003*

1.00
1.37
1.40

1.00
1.41

0.99-1.99

=.056

1.00
1.09

0.65-1.84

=.741

1.00
2.84

0.79-10.27

=.111

1.00
1.18
1.57

0.95-1.47
1.21-2.04

=.133
=.001*

1.00
1.09
1.81

0.81-1.45
1.13-2.92

=.583
=.014*

1.00
1.01
3.14

0.55-1.85
1.27-7.75

=.979
=.013*
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Variable
Multiple sex
partners in last 12
months
0
1
2+
Total lifetime
numbers of sex
partners
1
2
3+
Know a place to
get HIV test
No
Yes
Ever been tested
for HIV
No
Yes
Condom used last
time had sex with
most recent
partner
No
Yes

OR

Cameroon
95% CI
p-value

Cote d'Ivoire
OR 95% CI

p-value

Senegal
OR 95% CI

p-value

1.00
1.21
0.90

0.92-1.59
0.60-1.35

=.184
=.606

1.00
1.40
0.78

0.87-2.25
0.36-1.69

=.162
=.532

1.00
1.11
1.39

0.30-4.12
0.22-8.85

=.878
=.726

1.00
1.41
2.86

0.93-2.14
2.03-4.04

=.108
<.001*

1.00
1.59
2.54

0.99-2.54
1.66-3.89

=.053
<.001*

1.00
3.20
5.43

1.59-6.44
2.37-12.42

=.001*
<.001*

1.00
1.26

0.81-1.96

=.308

1.00
1.84

1.23-2.76

=.003

1.00
1.29

0.67-2.47

=.453

1.00
1.14

0.90-1.44

=.286

1.00
1.32

0.96-1.82

=.093

1.00
0.96

0.49-1.89

=.908

=.838

1.00
1.03

=.883

1.00
1.24

0.42-3.60

=.698

1.00
0.97

0.75-1.26

--This category was reduced

0.68-1.57

*p <.05

4.3.3. Multivariate Analysis of the Association between Selected Risk Factors and HIV
Status between Cameroon, Cote d’Ivoire and Senegal
Table 6 presents the results of the multivariate analysis of the association between
selected factors and HIV status among the three countries. After adjusting for the country
indicators and all the 13 other variables, 8 risk factors appeared significantly associated with
increases in the likelihood of HIV infection in both Cameroon and Cote d’Ivoire in reference to
Senegal. However, only ‘education level’ came out as a protective factor against HIV infection.
The greatest reduction in the likelihood of HIV infection (OR=0.53; 95% CI= 0.35, 0.83;
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p=.005) was among men and women with higher education background in both Cameroon and
Cote d’Ivoire in reference to Senegal. The results of the adjusted analysis showed Cameroon at
significantly greater increased odds (OR= 2.97; 2.18-4.03; p<.001) of HIV infection than Cote
d’Ivoire (OR=2.57; 1.89-3.50; p<.001) in reference to Senegal.
Also, the results of the adjusted analysis indicated that women were 2.18 times more
likely to have HIV infection compared to men in both Cameroon and Cote d’Ivoire in reference
to Senegal. Adults in their twenties and over also showed significant increases in the odds of
HIV prevalence with the highest increase (OR=2.81; 95% CI= 1.85, 4.26; p<.001) being among
men and women aged 40-49 in both Cameroon and Cote d’Ivoire in reference to Senegal. Adults
who were widowed or divorced also had 234% higher odds (OR=3.34; 95% CI= 2.22, 5.02;
p<.001) of being HIV positive compared to those who were never married in both Cameroon and
Cote d’Ivoire in reference to Senegal.
Further, adults who reported having had STI in the last 12 months (OR=1.33; 95% CI=
1.01, 1.77; p=.044) or received 5 and more injections in the last 12 months (OR=1.64; 95% CI=
1.32, 2.05; p<.001) were significantly associated with increased odds of HIV infection compared
to those who had not in both Cameroon and Cote d’Ivoire in reference to Senegal. Men and
women who had more than one lifetime sexual partner or one additional lifetime sexual partner
beside their wife or husband were significantly associated with increased likelihood of HIV
infection with the highest increase odds (OR=3.09; 95% CI= 2.40, 3.98; p<.001) being among
those who had two and more lifetime sexual partners in both Cameroon and Cote d’Ivoire in
reference to Senegal. Those who knew a place to get AIDS test were also significantly associated
with an increase in the likelihood of HIV infection (OR=1.52; 95% CI= 1.17, 1.99; p=.002)
compared to those who did not in both Cameroon and Cote d’Ivoire in reference to Senegal.
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Table 6 Multivariate analysis of the association between selected risk factors and
HIV status between Cameroon (2011), Cote d’Ivoire (2011-2012), and Senegal
(2010-2011)
Variable
Country
Senegal
Cote d’Ivoire
Cameroon
Gender
Male
Female
Age
15-19
20-29
30-39
40-49
Educational level
No education
Primary
Secondary
Higher
Current marital status
Never in union
Married/Living with a partner
Widowed/Divorced
Separated/No longer living together
Wealth index
Poor
Middle
Rich
Age at first sex
Never had sex
Before 15
15+
STI in last 12 months
No
Yes
Number of injections in last 12 months
None
1-4
5+
Multiple sexual partners in last 12 months
0
1
2+

OR

95% CI

p-value

1.00
2.57
2.97

1.89-3.50
2.18-4.03

<.001*
<.001*

1.00
2.18

1.82-2.61

<.001*

1.00
1.78
2.50
2.81

1.21-2.63
1.67-3.74
1.85-4.26

=.003*
<.001*
<.001*

1.00
0.88
0.73
0.53

0.71-1.10
0.57-0.94
0.35-0.83

=.269
=.015*
=.005*

1.00
1.60
3.34
2.02

1.19-2.17
2.22-5.02
1.38-2.96

=.002*
<.001*
<.001*

1.00
0.93
1.14

0.75-1.15
0.95-1.38

=.487
=.170

1.00
1.32
1.03

0.47-3.68
0.37-2.84

=.597
=.957

1.00
1.33

1.01-1.77

=0.044*

1.00
1.14
1.64

0.96-1.35
1.32-2.05

=.126
<.001*

1.00
1.26
0.89

1.00a-1.59
0.62-1.26

=.054
=.499
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Variable
Total lifetime numbers of sexual partners
1
2
3+
Know a place to get HIV test
No
Yes
Ever been tested for HIV
No
Yes
Condom used last time had sex with most
recent partner
No
Yes

a-rounded up to the nearest tenth

OR

95% CI

p-value

1.00
1.72
3.09

1.29-2.19
2.40-3.98

<.001*
<.001*

1.00
1.52

1.17-1.99

=.002*

1.00
1.20

1.00a-1.44

=.053

1.00
1.01

0.82-1.26

=.902

*p <.05

4.4. Best Predictive Risk Factors of HIV Infection and their Contribution to Variations in
HIV Prevalence in Cameroon, Cote d’Ivoire, and Senegal
This section presents the results of the forward stepwise likelihood ratio (Forward LR)
analysis in an attempt to answer the study question #4. Forward LR was performed to
identify which of the following nine HIV risk factors resulting from the multivariate analysis
of each country, gender, age, educational level, current marital status, wealth index, age at
first sex, number of injections, total lifetime numbers of sex partners, and know a place to get
AIDS test, are best in predicting the acquisition of HIV infection in Cameroon, Cote d’Ivoire
and Senegal.
The resulting model suggested seven best predictors of HIV infection in Cameroon. They
were gender, age, current marital status, age at first sex, number of injections, total lifetime
numbers of sex partners, and know a place to get AIDS test (Table 7). The model summary
shows that the overall model was a good fit (-2Log Likelihood= 3973.103; Hosmer and
Lemeshow goodness-of-fit test statistic p=.069). Also, the model was statistically significant
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(ᵡ2= 332.79, df= 13, p<.001) and all the predictors together accounted for 9.3% of the
variations (Nagelkerke R2= .093) in HIV prevalence in Cameroon. The model was accurate
in correctly classifying 94.8% of all cases (Table 8).
In Cote d’Ivoire, the results of Forward LR logistic regression pointed to 5 risk factors as
the best predictors of HIV infection including gender, age, current marital status, lifetime
numbers of sex partners, and know a place to get AIDS test (Table 7). Table 8 shows that the
overall model of five predictors was a good fit (-2Log Likelihood= 2096.534; Hosmer and
Lemeshow goodness-of-fit test statistic p=.094). Also, the overall model was statistically
significant (ᵡ2= 174.97, df= 10, p<.001) and all the five predictors contributed to 8.9% of the
variations (Nagelkerke R2= .097) in HIV prevalence of Cote d’Ivoire. The model was accurate in
correctly classifying 96.1% of all cases.
In Senegal, the results of the forward stepwise LR analysis presented 4 risk factors as best
predictive risk factors of HIV prevalence. This included gender, age, wealth index, and total
lifetime numbers of sex partners (Table 7). The overall model of four predictors was a good fit (2Log Likelihood= 734.576; Hosmer and Lemeshow goodness-of-fit test statistic p=.860). Also,
the model was statistically significant (ᵡ2= 54.21, df= 8, p<.001), and all the predictors together
could explain 7.3% of the variations (Nagelkerke R2= .073) in HIV prevalence. The model was
accurate in correctly classifying 98.8% of all cases (Table 8).
As shown in Table 7, three best predictors were common to all three countries in spite of
their differences. They were gender, age, and total lifetime numbers of sex partners. Further,
current marital status and knowledge of place for HIV testing were found to best predict HIV
prevalence in both Cameroon and Cote d’Ivoire. Finally, the results indicated that Cameroon had
more HIV predictors than Cote d’Ivoire or Senegal.
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Table 7 Best predictive risk factors of HIV prevalence in Cameroon (2011), Cote d’Ivoire
(2011-2012), and Senegal (2010-2011) – Results of Forward Stepwise Likelihood Ratio
Variable
Gender
Male
Female
Age
15-19
20-29
30-39
40-49
Current marital
status
Never in union
Married/Living
with a partner
Widowed/
Divorced
Separated/No
longer living
together
Wealth index
Poor
Middle
Rich
Age at first sex
Never had sex
Before 15
15+
Number of
injections in
last 12 months
None
1..4
5+
Total lifetime
numbers of sex
partners
0
1
2+
Know a place
to get HIV test
No
Yes
*p<.05

Cameroon
OR 95% CI

p-value

Cote d'Ivoire
OR
95% CI

1.79-3.20

<.001*

1.00
3.81

1.22-5.99
2.23-11.43
3.15-16.65

=.014*
<.001*
<.001*

1.00
1.28
2.02
3.40

1.00
2.13

1.75-2.60

<.001*

1.00
2.39

1.00
1.95
2.80
2.33

1.25-3.04
1.77-4.44
1.44-3.78

=.003*
<.001*
=.001*

1.00
2.70
5.04
7.24

1.00

p-value

Senegal
OR 95% CI

p-value

2.04-7.13

<.001*

0.37-4.41
0.60-6.81
1.02-11.35

=.694
=.255
=.047*

1.00
0.52
0.47

0.28-0.96
0.26-0.85

=.038*
=.014*

1.00
2.79
5.45

1.54-5.06
2.80-10.60

=.001*
<.001*

1.00

1.00

1.49

1.12-1.98

=.006*

1.25

0.85-1.82

=.255

3.94

2.61-5.94

<.001*

3.04

1.66-5.56

<.001*

2.68

1.82-3.95

<.001*

1.08

0.55-2.15

=.817

…
1.00
0.71

1.00
1.24
1.69

…

…

0.58-0.88

<.001*

1.01-1.51
1.33-2.14

=.036*
<.001*

1.00
1.45
2.88

1.00-2.11
2.14-3.87

1.00
1.59

1.08-2.33

=.049*
<.001*

1.00
1.77
2.56

1.12-2.61
1.75-3.73

=.012*
<.001*

.020*

1.00
2.09

1.54-2.84

<.001*
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Table 8 Model summary of best predictive risk factors of HIV prevalence in Cameroon (2011),
Cote d’Ivoire (2011-2012), and Senegal (2010-2011) – Results of Forward Stepwise Likelihood
Ratio
Number of variables in model
-2Log Likelihood (LL)

Cameroon
7
3973.103

Cote d'Ivoire
5
2096.534

Senegal
4
734.576

Hosmer and Lemeshow (H-L)
goodness-of-fit test statistic

p =.069

p =.094

p =.860

x2/ df /p-value

332.79/

Nagelkerke R2

0.093

0.089

0.073

Classification accuracy

94.8%

96.10%

98.80%

13

/<.001*

*p<.05

74

174.97/

10

/<.001*

54.21/

8

/<.001*

CHAPTER V
DISCUSSION AND CONCLUSION

5.1. Discussion
The purpose of the study was to explore differences in HIV risk factors that help explain
variations in HIV prevalence between Cameroon, Cote d’Ivoire, and Senegal. The study
achieved its goal by 1) identifying and comparing risk factors between the three African
countries 2) identifying and comparing the prevalence of HIV infection between the three
countries, and assessing its distribution by socio-demographics; 3) determining risk factors that
are associated with the prevalence of HIV infection in each country; and 4) identifying best
predictors of HIV prevalence and their contribution to variations in HIV prevalence within each
country. Finding best predictive risk factors and their degree of contribution might assist in
shaping effective prevention interventions, and therefore advancing preventive efforts in each
country to help eliminate the gap in HIV prevalence between the three countries.
5.1.1. Differences in Risk Factors between Cameroon, Cote d’Ivoire, and Senegal
The study found significant (p<.001) differences in the characteristics of the three countries
in regards to all 13 risk factors. Women were more represented in all three countries compared to
men. However, Senegal has more women representation than does Cameroon or Cote d’Ivoire.
Young adults aged 20-29 were represented in majority in all three countries than all the other age
groups. However, there were more young adults aged 20-29 in Cote d’Ivoire than in Cameroon
and Senegal. The majority of men and women in all three countries were married or living
together; however, a high proportion of this group resided in Cote d’Ivoire than in Cameroon or
Senegal. Further, more rich people were in Cameroon than in Senegal or Cote d’Ivoire. Thus,

75

these findings provided clear evidence of the differences between the socio-demographic
characteristics of the three countries.
Further, the practice of polygyny was the same in all three countries. However, there
were significant (p<.001) differences in the characteristics of sexual behaviors among men and
women of the three countries. More women and men reported they were sexually active before
the age of 15, had multiple sexual partners, and one additional lifetime sexual partner besides
wife or husband in Cote d’Ivoire than in Senegal or Cameroon. These findings were consistent
with the 2013 Global report (UNAIDS, 2013) that highlighted an increase in the number of
sexual partners in Cote d’Ivoire. However, more men and women embraced polygynous lifestyle
in Cameroon compared to those in Cote d’Ivoire or Senegal.
More adults reported they had had STI in the last 12 months in Cote d’Ivoire compared to
Cameroon or Senegal. Also, a higher proportion of men and women indicated they had received
5 and more injections in the last 12 months, knew a place to get HIV test, had ever been tested
for HIV, and used condom last time had sex with most recent partner in Cameroon than in Cote
d’Ivoire or Senegal. These differences in risky behaviors between the three countries are another
clear indication of the differences in characteristics of the three countries.
Interestingly, men and women in all three countries were struggling in changing their
behavior. Even though the majority of adults in all three countries indicated they knew a place to
get HIV test, only less than a half indicated they had ever been tested for HIV. More, only
quarter or less of those people stated they used condom last time they had sex with their most
recent partner. These findings are consistent with the 2013 Global Report (UNAIDS, 2013)
which indicated that several countries had noticed a reduction in the use of condoms among men
and women.
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5.1.2. Distribution of HIV Infection among Men and Women within and between
Cameroon (2011), Cote d’Ivoire (2011-2012), and Senegal (2010-2011): Gender Inequality
The findings pointed out the unevenly distribution of HIV prevalence among males and females
in all three countries. In Cameroon, women were almost twice affected by HIV infection than
men, and had the highest HIV prevalence age-wise than men. Women with primary or secondary
were the most infected with HIV compared to their fellow men. Those who were widowed or
divorced were 8 times more vulnerable to HIV infection compared to women who never got
married, and 2.5 times more than their men counterparts. Further, women who had their first sex
before the age of 15, had STI in the last 12 months, got 5 and more injections in the last 12
months, had one or more sexual partner(s) in addiction to husband, or 3 and over as lifetime
number of sexual partners, know a place to get HIV test, and had ever been tested for HIV were
the most affected by HIV infection compared to other women and compared to their male
counterparts.
The reasons of these gender inequalities are multiple including biological, medical, and
aesthetic factors, age of partner, poverty that left women financially powerless, status of
subordination that constrains them to polygamous life and weakens their ability to negotiate safer
sex, and cultural rules and discriminatory laws that undermine woman’ values. These findings
are consistent with previous studies and reports (Buve et al., 2012, Gay et al., 2012; NjikamSavage, 2005; Rwenge, 2013; UNAIDS, 2013). Accordingly, in its Global Report, UNAIDS
(2013) exhorted all countries to address the issue of gender disparities, abuse and violence, and
enable them to take control of their lives to reduce their vulnerability to HIV infection.
In Cote d’Ivoire, women were one and a half times likely to have HIV infection than
men. Like in Cameroon, women in Cote d’Ivoire had the highest HIV prevalence age-wise
compared to men. Women who were widowed or divorced were almost 6 times more vulnerable

77

to HIV infection compared to women who never got married, and 2.3 times more exposed to
HIV than their counterpart men. Further, women who had 3 and more lifetime number of sexual
partners, knew a place to get HIV test, and had ever been tested for HIV were the most
significantly infected with HIV compared to other women and compared to their male
counterparts. Even though those who had their first sex before 15 were not the most highly
affected among women, they were comparing to their male counterparts. These findings are
supported by previous studies (Hertog, 2008). In her study on gender differences between
Tanzania and Cote d’Ivoire, Hertog (2008) found also that polygamous marriage was protective
against HIV for men but not for women in Cote d’Ivoire. Her study showed that Muslim and
Protestant women living in polygamous marriage in Cote d’Ivoire were ten times more likely to
be HIV positive than their male counterparts. Thus, like in most African countries, women’
status of subordination, polygamous life, financial dependency, and other country-specific
contexts can also help explain gender disparities in Cote d’Ivoire.
In Senegal, the findings indicated that HIV prevalence was significantly unevenly
distributed among men and women on five risk factors. Women were 0.8 times more likely to
have HIV compared to their fellow men. Those in their forties and over and who were widowed
or divorced were the most affected by HIV infection compared to their male counterparts.
Women who had their first sex before 15 and had 3 and more lifetime partners were the most
HIV positive. Despite its lowest HIV prevalence in the region Senegal is still faced with some
challenges including gender differences, HIV epidemic with older people, girls’ early debut at
sex (15 years), multiple lifetime sexual partnership or polygyny. These findings are consistent
with those of previous studies and reports (ANSD, 2012; UNAIDS, 2013). As indicated above,
Hertog (2008) found in her study that men in polygamous marriage benefit more than women do.
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For men, polygamy union is protective while for women it is harmful. Our study found that
women who were in polygamous marriages (3 and more lifetime sexual partners) were 6.6 times
more likely to have HIV infection compared to other women who were in a single marriage and
3.3 times more likely to be HIV positive compared to their male counterparts. Senegal needs to
address these issues to avoid averting its privileged low HIV prevalence.
5.1.3. Association between Selected Risk Factors and HIV Prevalence in Cameroon (2011),
Cote d’Ivoire (2011-2012), and Senegal (2010-2011)
In Cameroon, the adjusted analysis found five risk factors including gender, age, current
marital status, number of injections in the last 12 months, and total lifetime numbers of sex
partners that remained significantly associated with increased odds of HIV infection. However,
delayed in sexual debut was found to be a protective factor against HIV infection. These results
are consistent with findings of previous studies and reports (Auvert et al., 2001; Buvé et al.,
2002; Gay et al., 2012; Njikam-Savage, 2005; Weiss et al., 2001; UNAIDS, 2013). The results of
the multivariate analysis highlighted the greater increased odds of HIV infection among adults
30 and over. Because a high number of older people are associated with HIV infection, it would
be interesting to extend our research scope beyond the age of 49 to understand and help capture
those undetected cases of HIV infection in the population. Often, studies focused on younger
adults and overlooked older population. These findings are also supported by previous research
(Gay et al., 2012). Therefore, further research is needed to shed light on older people’s cases for
effective prevention design.
In Cote d’Ivoire, the findings of the adjusted analysis showed seven risk factors, gender,
age, current marital status, wealth index, number of injections in the last 12 months, total lifetime
numbers of sex partners that remained strongly and significantly associated with increased odds
of HIV infection. On the other hand, having secondary or higher education background
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continued to associated with reduced odds of HIV infection. These results were consistent with
findings of previous studies and reports (Auvert et al., 2001; Gay et al., 2012; Hertog, 2008,
UNAIDS, 2013). The 2013 Global Report (UNAIDS, 2013) pointed out that there is evidence of
increase in risky behaviors including a rise in the number of sexual partners in Cote d’Ivoire.
However, there is limited research in these areas in Cote d’Ivoire.
In Senegal, the results of the multivariate analysis indicated only three risk factors as
strongly and significantly associated with increased odds of HIV infection. Based on the
extensive history of Senegal in having control of HIV infection and keeping its prevalence low at
all times, it is not surprising that it had fewer risk factors than the other two countries. These
findings are consistent with previous studies and reports (Foley & Nguer, 2010; Willems, 2009;
UNAIDS, 2013)
Having received 5 and more injections in the last 12 months was strongly associated with
increased odds of HIV infection in all three countries. It has been extensively documented that
contaminated syringes and needles are major sources of HIV acquisition among those who
shared injection equipment (Gay et al., 2012; Growing et al., 2013; Reid, 2009). Reid (2009) in
his review reported that medical injections with used syringes and needles during invasive
medical and dental care constituted a risk factor for the acquisition of HIV infection. Also, it has
been documented that injection drug use is no more unusual phenomenon in the sub-Saharan
African region. Accordingly, prevention interventions need to seriously take into consideration
this risk factor to help control HIV transmission in Cameroon, Cote d’Ivoire and Senegal.
Further, total lifetime number of sexual partners was strongly and significantly associated
with being HIV positive in all three countries with the highest odds of HIV infection being
observed among those with two and more lifetime sexual partners. The results shed light onto the
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polygamous nature of African society that is deeply rooted in political power and social forces
(UNAIDS, 2010; Buve et al, 2002; Mah & Shelton, 2011). Only through structural changes and
at the national scale that individual behavior change will occur.
The results of unadjusted analysis highlighted condom use with most recent partner as a
protective factor against HIV infection. Nevertheless, many men and women in both Cameroon
and Cote d’Ivoire still avoid using it or use it sporadically. According to Njikam-Savage (2005),
the lack of condom use among university students were due to many reasons including
promotion of active sexual engagement and infidelity, commercial profits, repulsion towards
condoms, and inability to negotiate condom use with older partners. In their review, Gay et al.,
(2012) found women powerless regarding the use of condoms since men have the ultimate
decision. The Global report (UNAIDS) stressed the lack of condom use in Cote d’Ivoire and
other countries in the Sub-Saharan African region. Accordingly, it is preponderant that
prevention programs adopt strategies that make condom use socially acceptable.
Thus, the adjusted analysis in each country showed that Cameroon has less independent
risk factors compared to Cote d’Ivoire that are associated with having HIV infection. This let us
to the challenge of how to best establish the relationship between differences in risk factors and
variations in HIV prevalence with Cameroon having the highest HIV prevalence (4.3%)
compared to Cote d’Ivoire (3.7%)? The remaining lines will help us shed light on the
relationship.
5.1.4. Association between Selected Risk Factors and HIV Prevalence between Cameroon
(2011), Cote d’Ivoire (2011-2012), and Senegal (2010-2011)
The results of the adjusted logistic regression among countries demonstrated that each
country as whole was strongly, significantly, and independently associated with increased odds
of HIV prevalence in comparison to Senegal. This implies that there were factors above and
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beyond differences in risk factors that also can help explain variations in the prevalence of HIV.
In their paper, international response to the HIV/AIDS epidemic: planning for success, Piot and
Seck (2001) argued that the society in which successful responses to the HIV epidemic has been
achieved and HIV prevalence and incidence have been maintained low is the nation where
political leaders, and national and local communities have identified effective priorities for
action, initiated deeper social structure changes, and expanded availability of relevant resources.
They state “…it is precisely when the response to the epidemic is based on a broad social
mobilization, accompanied by clear deliverables, that success has been achieved” (p. 1108).
These claims are consistent with the 2013 Global Report (UNAIDS, 2013) that
highlighted many countries’ lack in the thorough and rigorous approach that will assist them in
moving forward. The report also indicated that the prevention strategies should not be
implementing in isolation but taking into account the local need of the population or the local
context. The 2013 Global Report stipulates “It is clear that only when a comprehensive set of
HIV prevention initiatives is rolled out at a national scale with sufficient access to, and frequent
use of, qualities services, will countries realize the optimal prevention returns” (p.14).
Therefore, UNAIDS (2013) suggested that new prevention efforts combine behavioral,
biomedical, and structural programming approaches to help speed up the progress. This
recommendation is consistent with the study. Prevention priorities should take into consideration
country-specific context to help speed the progress in the fight for HIV.
As expected and in comparison to Senegal, all the risk factors that were significantly
associated with HIV infection were all at increased odds except one, ‘education level.’ In its
introduction and literature review, the study has highlighted the historical advantage and the
many initiatives including political and local involvement, social and economic contexts, cultural
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strongholds, scientific research which Senegal has undertaken to help its society sustain the low
HIV prevalence and incidence. On the other hand, Cameroon and Cote d’Ivoire have seen some
of these critical elements missing in their prevention efforts. Particularly, the decade of civil war
and political instability that had torn Cote d’Ivoire and the presence of virulent HIV strains
(Buvé, 2002; Nsagha et al., 2012) and the lack of rigorous oversight of HIV (Yakam & Gruénais,
2009) prevention programs in Cameroon could be serious limitations to the reduction in HIV
prevalence and incidence comparable to the level of Senegal. Therefore, these findings brought
into light the importance of taking into consideration many of the factors that are beyond HIV
prevention scope if effective prevention efforts will be achieved. Further, the results of
educational level demonstrated that a reduced number of adults with secondary and higher
education background were associated with HIV infection compared to Senegal. Even though
more people are educated in Cameroon than in Cote d’Ivoire, the examination of the results of
univariate and multivariate of ‘educational level’ indicated that more men and women in Cote
d’Ivoire are aligning their knowledge to their actions than people in Cameroon do.
5.1.5. Best Predictors of HIV Infection in Cameroon, Cote d’Ivoire, and Senegal
The results of Forward LR substantiated that there were differences in risk factors among
the three countries and some of those risk factors were strongly and significantly associated with
being infected with HIV. The fact that Cameroon has the highest HIV prevalence (4.3%) and
showed more best predictive risk factors (7) that are strongly and significantly associated with
HIV infection while Cote d’Ivoire has 3.7% as HIV prevalence and presents less best predictors
(5) with some significant tied to the disease might help explain both countries’ differences in risk
factors and their association to variations in the prevalence of HIV. As also evidenced by the
Nagelkerke R squared, all the identified best predictors together accounted for 9.3% of variations
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in HIV prevalence in Cameroon whereas in Cote d’Ivoire, all the identified best predictive risk
factors together could explain 8.9% of variations in HIV prevalence (Table 4.4.2). Not
surprising, Senegal with its lowest HIV prevalence (0.7%) had the lowest identified best
predictors (4) compared to those of Cameroon or Senegal. These few identified best predictive
risk factors were not all strongly associated with HIV infection.
Thus, the major findings of the study are that differences in risk factors can help explain
variations in HIV prevalence. However, these differences accounted only for a portion of the
variation in HIV prevalence. Accordingly, country indicators’ strong association with HIV
prevalence suggests there are other factors above and beyond risk factors that can capture the
unexplained variations of HIV prevalence.
5.2. Strengths and Study Limitations
Because DHS surveys phase 6 were population-based surveys, collected datasets were
nationally representative samples of the three countries, Cameroon, Cote d’Ivoire, and
Senegal. Also, HIV sample weights were applied to both women and men datasets for all
three countries when assessing frequency counts and percentages, or distributions.
Accordingly, the study results could be generalized to the entire population of each country.
Also, the study shed light onto the countries’ strong and significant indication that not all the
difference in HIV prevalence is captured by risk factors but only some of it is.
This study has some limitations. First, because of the nature of the study design and DHS
data collection which were cross-sectional, no causality of identified risk factors could be
considered. Second, the study used secondary data which limited flexibility and required
research questions to fit data. Third, the timeframe of data collection for each Cameroon and
Senegal overlapped while that of Cote d’Ivoire slightly differed. This slight gap in data
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collection might limit the interpretation of results. Fourth, DHS survey relies on respondents’
self-report; accordingly, data could be prone to normative and recall bias, and therefore
should be interpreted be caution. Indeed, because of the sensitiveness of many questions,
respondents particularly women might misreport or underreport information deemed private
or critical to the survival of their marriage, their dignity, or safety in African society. Also,
participants may not recall sexual partners they had had in the past particularly in regard to
the question related to total lifetime partnerships. Fifth, some variables had limited or
missing data, which might reflect on the analysis of results.
5.3 Implications for HIV Prevention Programs and Public Health Policy
Prevention measures should embrace structural changes at a national or societal scale. The
country indicators revealed that there are variations in HIV prevalence that are not explained by
differences in risk factors. Accordingly, prevention efforts need to take into consideration
country-specific context in order to scale up progress in the fight against the disease.
Also, prevention interventions should direct their attention on older adults. Most of the
prevention programs have been toward young adults overlooking this group of people. Further,
prevention efforts should address the issue of gender disparities and poverty in the sub-Saharan
African region. Many women widowed or divorced engaged in sex exchanges in order to support
their children. Unless we direct our focus on sources of gender inequality in the region, the
prevalence of HIV among women will remain high and prevention efforts will be vain.
Prevention programs should ensure that condoms are free and available to young adults to
allow them to view condom use as true preventive measures instead of profit-making. Female
condom should be promoted to allow women to take control of their body and counter their
inability to negotiate safer sexual intercourses.
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Because drug injection users (DIU) are rapidly increasing in number in the Sub-Saharan
region, it is necessary that public health decision-makers work in collaboration with law makers
to help eradicate punitive measures that prevent DIUs from seeking health and social services.
Public health policies should ensure all medical and dental care abide by the rules and laws and
use only unopened and clean syringes and needles for each patient particularly in rural and
remote areas.
5.4 Conclusion
There are considerable differences in risk factors among the three countries. These risk factors
are strongly and significantly associated with having HIV infection. Also, the comparison of the
association between risk factors and HIV infection among countries showed a strong and
significant association between country indicators and the acquisition of HIV infection. This led
us to conclude that differences in risk factors can help explain variations in HIV prevalence.
However, only part of the variation is captured by the risk factors. These findings have
implications for intervention design and public health policy. More research is needed to shed
light on variations in HIV prevalence that are above and beyond the contribution of differences
in risk factors.
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